{
  "meta": {
    "id": "test74",
    "title": "Mid Day Module (PSM-7) - 2025-02-19",
    "category": "Subject Wise / Mixed"
  },
  "questions": [
    {
      "text": "Mrs. X brought her 8-year-old child to the hospital with symptoms suggestive of Rheumatic Heart Disease, and the child was found to have carditis. The medical officer initiated treatment with an injection of Benzathine Penicillin. For how long should this child continue to receive regular Benzathine Penicillin injections for secondary prophylaxis of Rheumatic Heart Disease?",
      "options": [
        {
          "label": "A",
          "text": "10 years",
          "correct": false
        },
        {
          "label": "B",
          "text": "15 years",
          "correct": false
        },
        {
          "label": "C",
          "text": "20 years",
          "correct": false
        },
        {
          "label": "D",
          "text": "25 years",
          "correct": true
        }
      ],
      "correct_answer": "D. 25 years",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/09/screenshot-2024-08-09-095627_v4BAZwr.png",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/09/screenshot-2024-08-09-100207.png"
      ],
      "explanation": "<p><strong>Ans. D. 25 years</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Prevention of RF with Benzathine benzyl penicillin :</li><li>\u2022 Prevention</li><li>\u2022 RF</li><li>\u2022 Benzathine benzyl penicillin</li><li>\u2022 Oral penicillin (Penicillin V or G) X 10 days is the \u2018least expensive method\u2019 of giving penicillin to eradicate Streptococci from throat</li><li>\u2022 Oral penicillin</li><li>\u2022 10 days</li><li>\u2022 \u2018least expensive method\u2019</li><li>\u2022 penicillin</li><li>\u2022 Streptococci from throat</li><li>\u2022 Secondary prevention for patients with carditis: Continue for 10 yrs after the last attack or at least until 25 yrs age (whichever is longer)</li><li>\u2022 10 yrs after the last attack or at least until 25 yrs age (whichever is longer)</li><li>\u2022 RHEUMATIC FEVER (RF)</li><li>\u2022 RHEUMATIC FEVER (RF)</li><li>\u2022 Causative agent : Group A beta hemolytic streptococci \u2013 Serotype M type 5 has highest rheumatogenic potential Recently Coxsackie virus B4 has been suggested as a \u2018causative factor\u2019 & Streptococcus acting as a \u2018conditioning agent\u2019 RF is a disease of childhood & adolescence (5\u201315 yrs) affecting both sexes equally RF is not a communicable disease : but it results from a communicable disease (streptococcal pharyngitis) MC cause of Heart disease in 5-30 yrs age group (globally): RF Prevalence of RHD in India : 5-7 per 1000 in 5\u201315 yrs age group RF occurs in 1\u20133% of Streptococcal infection Eradication of Grp A Streptococcus is not possible: Due to high carrier rate MC cardiac lesion seen in RF: \u2013 In children: Mitral regurgitation; In adults: Mitral stenosis MC ECG finding in RF: First degree AV block Diagnosis of RF is by employing NEW Revised Jones criteria -</li><li>\u2022 Causative agent : Group A beta hemolytic streptococci \u2013 Serotype M type 5 has highest rheumatogenic potential Recently Coxsackie virus B4 has been suggested as a \u2018causative factor\u2019 & Streptococcus acting as a \u2018conditioning agent\u2019</li><li>\u2022 Causative agent</li><li>\u2022 Group A beta hemolytic streptococci</li><li>\u2022 Recently Coxsackie virus B4 has been suggested as a \u2018causative factor\u2019 & Streptococcus acting as a \u2018conditioning agent\u2019</li><li>\u2022 Recently Coxsackie virus B4 has been suggested as a \u2018causative factor\u2019 & Streptococcus acting as a \u2018conditioning agent\u2019</li><li>\u2022 RF is a disease of childhood & adolescence (5\u201315 yrs) affecting both sexes equally</li><li>\u2022 disease of childhood</li><li>\u2022 adolescence</li><li>\u2022 both sexes equally</li><li>\u2022 RF is not a communicable disease : but it results from a communicable disease (streptococcal pharyngitis)</li><li>\u2022 not a communicable disease</li><li>\u2022 MC cause of Heart disease in 5-30 yrs age group (globally): RF</li><li>\u2022 MC</li><li>\u2022 Heart disease in 5-30 yrs age group</li><li>\u2022 Prevalence of RHD in India : 5-7 per 1000 in 5\u201315 yrs age group</li><li>\u2022 Prevalence of RHD in India</li><li>\u2022 5-7 per 1000</li><li>\u2022 5\u201315 yrs age group</li><li>\u2022 RF occurs in 1\u20133% of Streptococcal infection</li><li>\u2022 Eradication of Grp A Streptococcus is not possible: Due to high carrier rate</li><li>\u2022 MC cardiac lesion seen in RF: \u2013 In children: Mitral regurgitation; In adults: Mitral stenosis</li><li>\u2022 MC ECG finding in RF: First degree AV block</li><li>\u2022 Diagnosis of RF is by employing NEW Revised Jones criteria -</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Treatment for RF - one intramuscular injection of benzathine benzyl penicillin (1.2 million units in adults and 600,000 units in children) at intervals of 3 weeks . This must be continued for at least 5 years or until the child reaches 18 years , whichever is later.</li><li>\u27a4 Treatment for RF</li><li>\u27a4 one intramuscular injection</li><li>\u27a4 benzathine benzyl penicillin</li><li>\u27a4 intervals of 3 weeks</li><li>\u27a4 continued</li><li>\u27a4 least 5 years</li><li>\u27a4 child reaches 18 years</li><li>\u27a4 For patients with carditis (mild mitral regurgitation or healed carditis) the treatment should continue for 10 years after the last attack , or at least until 25 years of age , whichever is longer. More severe valvular disease or post-valve surgery cases need life-long Treatment.</li><li>\u27a4 carditis</li><li>\u27a4 treatment</li><li>\u27a4 continue for 10 years</li><li>\u27a4 last attack</li><li>\u27a4 at least until 25 years of age</li><li>\u27a4 Ref : Park 26 th ed pg 425.</li><li>\u27a4 Ref : Park 26 th ed pg 425.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "05eb5d6b",
      "audio": ""
    },
    {
      "text": "An intern is discussing the nature of chronic diseases with her supervisor. She is reviewing the characteristics that typically define these conditions. Which of the following is NOT a characteristic feature of chronic diseases?",
      "options": [
        {
          "label": "A",
          "text": "Permanent",
          "correct": false
        },
        {
          "label": "B",
          "text": "Leave residual disability",
          "correct": false
        },
        {
          "label": "C",
          "text": "Reversible pathological alteration",
          "correct": true
        },
        {
          "label": "D",
          "text": "Require special training of the patient for rehabilitation",
          "correct": false
        }
      ],
      "correct_answer": "C. Reversible pathological alteration",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Reversible pathological alteration</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Permanent . Correct</li><li>\u2022 Option A.</li><li>\u2022 Permanent</li><li>\u2022 Option B. Leave residual disability . Correct</li><li>\u2022 Option B.</li><li>\u2022 Leave residual disability</li><li>\u2022 Option D. Require special training of the patient for rehabilitation . Correct</li><li>\u2022 Option D.</li><li>\u2022 Require special training of the patient for rehabilitation</li><li>\u2022 The Commission on Chronic Illness in USA has defined \u201cchronic diseases \u201d as \u201ccomprising all impairments or deviations from normal , which have one or more of the following characteristics -</li><li>\u2022 Commission on Chronic Illness</li><li>\u2022 USA</li><li>\u2022 \u201cchronic diseases</li><li>\u2022 \u201ccomprising all impairments</li><li>\u2022 deviations from normal</li><li>\u2022 Are Permanent Leave residual disability Are caused by non-reversible pathological alteration Require special training of the patient for rehabilitation May be expected to require a long period of supervision, observation, or care.\u201d</li><li>\u2022 Are Permanent</li><li>\u2022 Leave residual disability</li><li>\u2022 Are caused by non-reversible pathological alteration</li><li>\u2022 Require special training of the patient for rehabilitation</li><li>\u2022 May be expected to require a long period of supervision, observation, or care.\u201d</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Chronic diseases are - typically permanent , often leave residual disability , and may require rehabilitation training , but they are not characterized by reversible pathological alterations.</li><li>\u27a4 Chronic diseases</li><li>\u27a4 permanent</li><li>\u27a4 leave residual disability</li><li>\u27a4 require rehabilitation training</li><li>\u27a4 Ref : Park 26 th ed pg 407</li><li>\u27a4 Ref : Park 26 th ed pg 407</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b6012486",
      "audio": ""
    },
    {
      "text": "A medical student is studying public health trends and comes across the term \"epidemiological transition.\" Which of the following statements best describes this concept?",
      "options": [
        {
          "label": "A",
          "text": "Transition from high mortality to low mortality",
          "correct": false
        },
        {
          "label": "B",
          "text": "Transition from high birth rate to high death rate",
          "correct": false
        },
        {
          "label": "C",
          "text": "Transition from communicable diseases to non-communicable diseases",
          "correct": true
        },
        {
          "label": "D",
          "text": "Transition from under nutrition to obesity",
          "correct": false
        }
      ],
      "correct_answer": "C. Transition from communicable diseases to non-communicable diseases",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Transition from communicable diseases to non-communicable diseases.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Epidemiological transition is a gradual process by which disease profile of a community in a nation passes from one of predominantly communicable to one which is predominated by NCDs . Epidemiological transition: A change in the pattern of disease in a country away from infectious diseases towards degenerative diseases</li><li>\u2022 Epidemiological transition</li><li>\u2022 gradual process</li><li>\u2022 disease profile</li><li>\u2022 community</li><li>\u2022 nation passes</li><li>\u2022 predominantly communicable</li><li>\u2022 predominated by NCDs</li><li>\u2022 change in the pattern of disease</li><li>\u2022 country</li><li>\u2022 Other important terminologies -</li><li>\u2022 Other important terminologies -</li><li>\u2022 Demographic trap: Applies to a country whose population is growing rapidly due to a high BR and low DRQ</li><li>\u2022 Demographic trap:</li><li>\u2022 country</li><li>\u2022 population is growing rapidly</li><li>\u2022 Demographic gift: The initially favorable effect of falling fertility rates on the ratio of the working population to the dependent population</li><li>\u2022 Demographic gift:</li><li>\u2022 initially favorable effect</li><li>\u2022 falling fertility rates</li><li>\u2022 ratio of the working population</li><li>\u2022 Demographic dividend: A rise in the rate of economic growth due to a rising share of working age people in a population . It usually occurs late in the demographic transition when the fertility rate falls and the youth DR declines. In this demographic window opportunity, output per capita rises</li><li>\u2022 Demographic dividend:</li><li>\u2022 rise in the rate of economic growth</li><li>\u2022 rising share</li><li>\u2022 working age people</li><li>\u2022 population</li><li>\u2022 Demographic transition: is a model used to explain the process of transition from high BR and high DR to low BR and low DR as part of the economic development of a country from a preindustrial to an industrialized economy</li><li>\u2022 Demographic transition:</li><li>\u2022 model</li><li>\u2022 process of transition</li><li>\u2022 high BR</li><li>\u2022 high DR</li><li>\u2022 low BR</li><li>\u2022 low DR</li><li>\u2022 Demographic Window: Period of time in a when \u2018proportion of population of working age group is particularly prominent\u2019. Typically, the demographic window of opportunity lasts 30\u201340 years</li><li>\u2022 Demographic Window:</li><li>\u2022 Period of time</li><li>\u2022 when</li><li>\u2022 \u2018proportion of population of working age group is particularly prominent\u2019.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Epidemiological transition - A change in the pattern of disease in a country away from infectious diseases (communicable diseases) towards degenerative diseases (NCDs)</li><li>\u27a4 Epidemiological transition</li><li>\u27a4 change in the pattern</li><li>\u27a4 disease</li><li>\u27a4 country away from infectious diseases</li><li>\u27a4 degenerative diseases</li><li>\u27a4 Ref : Textbook of community medicine by Rajvir Balwar, 4 th ed, pg 902</li><li>\u27a4 Ref : Textbook of community medicine by Rajvir Balwar, 4 th ed, pg 902</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "bd65e161",
      "audio": ""
    },
    {
      "text": "A medical student is studying the influence of behavioral risk factors on health outcomes. Understanding that certain lifestyle choices and behaviors significantly increase the risk of developing various diseases is crucial for preventative medicine. The student is reviewing a list of diseases, trying to identify which one is NOT typically associated with behavioral risk factors. Which of the following diseases is generally not linked to behavioral risk factors?",
      "options": [
        {
          "label": "A",
          "text": "Hypertension",
          "correct": false
        },
        {
          "label": "B",
          "text": "Diabetes mellitus",
          "correct": false
        },
        {
          "label": "C",
          "text": "Ovarian cancer",
          "correct": true
        },
        {
          "label": "D",
          "text": "Oral cancer",
          "correct": false
        }
      ],
      "correct_answer": "C. Ovarian cancer",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Ovarian cancer</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Hypertension: Behavioral risk factors such as a high-sodium diet , lack of physical activity, alcohol consumption, and smoking are well-known contributors to the development of hypertension.</li><li>\u2022 Option A. Hypertension:</li><li>\u2022 Behavioral risk factors</li><li>\u2022 high-sodium diet</li><li>\u2022 Option B. Diabetes Mellitus (DM): Type 2 DM is strongly linked to behavioral factors including diet, physical inactivity, and obesity.</li><li>\u2022 Option B. Diabetes Mellitus (DM):</li><li>\u2022 Type 2 DM</li><li>\u2022 linked to behavioral factors</li><li>\u2022 Option D. Oral Cancer: Oral cancer has several behavioral risk factors , including tobacco use (smoking and chewing), alcohol consumption, and potentially diet.</li><li>\u2022 Option D. Oral Cancer:</li><li>\u2022 several behavioral risk factors</li><li>\u2022 tobacco use</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 While hypertension, diabetes mellitus , and oral cancer are diseases commonly associated with behavioral risk factors , ovarian cancer is generally not linked to such factors and is more influenced by genetic, reproductive, and age-related factors.</li><li>\u27a4 hypertension, diabetes mellitus</li><li>\u27a4 oral cancer</li><li>\u27a4 diseases</li><li>\u27a4 behavioral risk factors</li><li>\u27a4 Ref : Textbook of community medicine by Rajvir Balwar, 4 th ed, pg 901</li><li>\u27a4 Ref : Textbook of community medicine by Rajvir Balwar, 4 th ed, pg 901</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8a7de61b",
      "audio": ""
    },
    {
      "text": "Mr. X, a 45-year-old male, presented to your outpatient department (OPD) for a preventive health checkup. He is concerned about his risk for cardiovascular diseases. Which of the following risk factors in Mr. X's profile are considered non-modifiable?",
      "options": [
        {
          "label": "A",
          "text": "Elevated serum cholesterol",
          "correct": false
        },
        {
          "label": "B",
          "text": "Stress",
          "correct": false
        },
        {
          "label": "C",
          "text": "Personality",
          "correct": true
        },
        {
          "label": "D",
          "text": "Obesity",
          "correct": false
        }
      ],
      "correct_answer": "C. Personality",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/09/screenshot-2024-08-09-094528.png"
      ],
      "explanation": "<p><strong>Ans. C. Personality</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Non-Modifiable Risk factor of CHD - Age, sex, family history, genetic factor, personality</li><li>\u2022 Other 3 options are modifiable risk factors</li><li>\u2022 Other 3 options</li><li>\u2022 Risk Factors for CHD</li><li>\u2022 Risk Factors for CHD</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Non-Modifiable Risk factor of CHD - Age, sex, family history, genetic factor, personality</li><li>\u27a4 Non-Modifiable Risk</li><li>\u27a4 CHD</li><li>\u27a4 Modifiable Risk factor of CHD - High BP, cigarette smoking, elevated serum cholesterol, DM, Obesity, sedentary habits, stress</li><li>\u27a4 Modifiable Risk factor of CHD</li><li>\u27a4 Ref : Park 26 th ed pg 414.</li><li>\u27a4 Ref : Park 26 th ed pg 414.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2c4643d9",
      "audio": ""
    },
    {
      "text": "A 55-year-old male with a family history of coronary heart disease (CHD) presents for a routine health evaluation. The patient is concerned about his risk of developing CHD and seeks advice on which clinical measurement would be most indicative of his immediate risk. As a physician, you assess various risk factors to determine which single factor might most significantly indicate his immediate risk for developing CHD. Which of the following clinical measurements would be most indicative of his IMMEDIATE risk for developing CHD?",
      "options": [
        {
          "label": "A",
          "text": "Smoking",
          "correct": false
        },
        {
          "label": "B",
          "text": "Raised Blood pressure",
          "correct": true
        },
        {
          "label": "C",
          "text": "Raised serum cholesterol",
          "correct": false
        },
        {
          "label": "D",
          "text": "Raised Blood Glucose",
          "correct": false
        }
      ],
      "correct_answer": "B. Raised Blood pressure",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Raised Blood pressure</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A.  Smoking: Smoking is a significant risk factor for CHD , but as a single measurement, it may not be as immediately indicative of CHD risk as some other clinical measurements, especially if the patient is not currently a smoker.</li><li>\u2022 Option A.  Smoking:</li><li>\u2022 significant risk factor for CHD</li><li>\u2022 Option C. Raised serum cholesterol: High cholesterol , particularly LDL cholesterol , is a critical risk factor for the development of atherosclerosis and CHD . However, its impact on immediate risk might be cumulative over time rather than immediate.</li><li>\u2022 Option C. Raised serum cholesterol:</li><li>\u2022 High cholesterol</li><li>\u2022 LDL cholesterol</li><li>\u2022 risk factor for the development of atherosclerosis</li><li>\u2022 CHD</li><li>\u2022 Option D. Raised blood glucose: Diabetes or impaired glucose tolerance is a risk factor for CHD . Like cholesterol, its impact is significant but might be more cumulative in nature.</li><li>\u2022 Option D. Raised blood glucose:</li><li>\u2022 Diabetes</li><li>\u2022 risk factor for CHD</li><li>\u2022 Some Important Pointers related to CHD</li><li>\u2022 Some Important Pointers related to CHD</li><li>\u2022 Single most useful test for identifying individuals at high risk of CHD: Blood pressure (Systolic BP better predictor of CHD than Diastolic BP) Most direct association with CHD: LDL cholesterol; Cholesterol/HDL ratio < 3.5; HDL cholesterol > 30 mg/dL Better predictors of CHD: Apolipoprotein A\u2013I and Apolipoprotein B Alcohol intake as an independent risk factor for CHD: > 75 grams per day Mean serum cholesterol level associated with high risk of CHD: >200 mg/dL ( Threshold level: 220 mg/dl is protective) Protective for CHD: HDL cholesterol (>30 mg/dl) Clinical goal of CHD prevention: Cholesterol/HDL ratio <3.5</li><li>\u2022 Single most useful test for identifying individuals at high risk of CHD: Blood pressure (Systolic BP better predictor of CHD than Diastolic BP)</li><li>\u2022 Most direct association with CHD: LDL cholesterol; Cholesterol/HDL ratio < 3.5; HDL cholesterol > 30 mg/dL</li><li>\u2022 LDL cholesterol;</li><li>\u2022 Better predictors of CHD: Apolipoprotein A\u2013I and Apolipoprotein B</li><li>\u2022 Better predictors of CHD: Apolipoprotein A\u2013I and Apolipoprotein B</li><li>\u2022 Alcohol intake as an independent risk factor for CHD: > 75 grams per day</li><li>\u2022 Mean serum cholesterol level associated with high risk of CHD: >200 mg/dL ( Threshold level: 220 mg/dl is protective)</li><li>\u2022 Mean serum cholesterol level associated with high risk of CHD: >200 mg/dL (</li><li>\u2022 Protective for CHD: HDL cholesterol (>30 mg/dl)</li><li>\u2022 Protective for CHD: HDL cholesterol (>30 mg/dl)</li><li>\u2022 Clinical goal of CHD prevention: Cholesterol/HDL ratio <3.5</li><li>\u2022 Clinical goal of CHD prevention: Cholesterol/HDL ratio <3.5</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Blood pressure is the single most useful test for identifying individuals at a high risk of developing CHD .</li><li>\u27a4 Blood pressure</li><li>\u27a4 single most useful test</li><li>\u27a4 identifying individuals</li><li>\u27a4 high risk</li><li>\u27a4 developing CHD</li><li>\u27a4 Ref : Park 26 th ed pg 414.</li><li>\u27a4 Ref : Park 26 th ed pg 414.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c56b9631",
      "audio": ""
    },
    {
      "text": "In a public health survey focusing on cardiovascular health, researchers evaluated various risk factors for Coronary Heart Disease (CHD) in a diverse urban population. Considering the biochemical parameters, which of the following is most directly associated with a high risk of CHD in this population?",
      "options": [
        {
          "label": "A",
          "text": "VLDL",
          "correct": false
        },
        {
          "label": "B",
          "text": "HDL",
          "correct": false
        },
        {
          "label": "C",
          "text": "Chylomicron",
          "correct": false
        },
        {
          "label": "D",
          "text": "LDL",
          "correct": true
        }
      ],
      "correct_answer": "D. LDL",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. LDL</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. VLDL: Very low-density lipoprotein (VLDL) has also been shown to be associated with premature atherosclerosis , it is more strongly associated with peripheral vascular disease than with CHD.</li><li>\u2022 Option A.</li><li>\u2022 VLDL:</li><li>\u2022 Very low-density lipoprotein</li><li>\u2022 premature atherosclerosis</li><li>\u2022 strongly associated</li><li>\u2022 peripheral vascular disease</li><li>\u2022 Option B. HDL . High-density lipoprotein (HDL) cholesterol is protective against the development of CHD</li><li>\u2022 Option B.</li><li>\u2022 HDL</li><li>\u2022 protective against</li><li>\u2022 development of CHD</li><li>\u2022 Option C. Chylomicron . Large triglyceride-rich particles made by the intestine , which are involved in the transport of dietary triglycerides and cholesterol to peripheral tissues and the liver . Abnormal chylomicron metabolism is associated with an atherogenic LDL profile. So, indirectly associated with CHD.</li><li>\u2022 Option C.</li><li>\u2022 Chylomicron</li><li>\u2022 Large triglyceride-rich particles</li><li>\u2022 intestine</li><li>\u2022 transport of dietary triglycerides</li><li>\u2022 cholesterol to peripheral tissues</li><li>\u2022 liver</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Most direct association with CHD - LDL cholesterol Ischemic heart disease is associated with mostly - LDL cholesterol Cholesterol with high-risk of CHD - LDL cholesterol</li><li>\u27a4 Most direct association with CHD - LDL cholesterol</li><li>\u27a4 direct association with CHD</li><li>\u27a4 LDL cholesterol</li><li>\u27a4 Ischemic heart disease is associated with mostly - LDL cholesterol</li><li>\u27a4 Ischemic heart disease</li><li>\u27a4 LDL cholesterol</li><li>\u27a4 Cholesterol with high-risk of CHD - LDL cholesterol</li><li>\u27a4 Cholesterol</li><li>\u27a4 high-risk of CHD</li><li>\u27a4 Ref : Park 26 th ed pg 415.</li><li>\u27a4 Ref : Park 26 th ed pg 415.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d0f711aa",
      "audio": ""
    },
    {
      "text": "A group of medical researchers are discussing landmark studies in cardiovascular disease. They focus on a pivotal long-term study that has significantly contributed to understanding the epidemiology and risk factors of Coronary Heart Disease (CHD). Which study are they most likely discussing?",
      "options": [
        {
          "label": "A",
          "text": "Stanford study",
          "correct": false
        },
        {
          "label": "B",
          "text": "Framingham study",
          "correct": true
        },
        {
          "label": "C",
          "text": "Oslo",
          "correct": false
        },
        {
          "label": "D",
          "text": "North Kerelia project",
          "correct": false
        }
      ],
      "correct_answer": "B. Framingham study",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Framingham study</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Stanford study (Stanford-three-community study) - The aim was to determine if community health education can reduce the risk of cardiovascular diseases . The Results showed the reduction of CVD by 23 \u2013 28%</li><li>\u2022 Option A. Stanford study</li><li>\u2022 aim was to determine</li><li>\u2022 community health education</li><li>\u2022 reduce the risk of cardiovascular diseases</li><li>\u2022 Option C. Oslo (Oslow diet/smoking intervention study) -</li><li>\u2022 Option C. Oslo</li><li>\u2022 Aim: To determine if serum lipids lowering and smoking-cessation would reduce incidence of first attack of CHD in 40-50 yrs males</li><li>\u2022 determine</li><li>\u2022 serum lipids lowering</li><li>\u2022 smoking-cessation</li><li>\u2022 reduce incidence</li><li>\u2022 first attack of CHD</li><li>\u2022 40-50 yrs males</li><li>\u2022 Results: Reduction of MI by 47%</li><li>\u2022 Importance: With this study, primary prevention of CHD entered practical field of preventive medicine in an impressive manner.</li><li>\u2022 Option D. North kerelia study/ Project -</li><li>\u2022 Option D. North kerelia study/ Project</li><li>\u2022 Aims: To reduce cardiovascular risk factor levels and to promote early diagnosis , treatment and rehabilitation of patients Results: Reduction seen in CHD deaths in 10 years</li><li>\u2022 reduce cardiovascular risk factor levels</li><li>\u2022 promote early diagnosis</li><li>\u2022 treatment</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Best known large risk factor study for CHD is - Framingham Heart Study</li><li>\u27a4 Best known large risk factor</li><li>\u27a4 CHD</li><li>\u27a4 Framingham Heart Study</li><li>\u27a4 Framingham Heart Study Is a classic example of cohort study</li><li>\u27a4 Framingham Heart Study</li><li>\u27a4 example</li><li>\u27a4 cohort study</li><li>\u27a4 Ref : Park 26 th ed pg 416</li><li>\u27a4 Ref : Park 26 th ed pg 416</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0fab7cdc",
      "audio": ""
    },
    {
      "text": "A famous law assumes that human population is static. But human population and consequently human gene pool is never static. A medical student studying for his board exams comes across this concept while revising the genetics section. Which of the following is this principle most closely related to?",
      "options": [
        {
          "label": "A",
          "text": "Gene therapy",
          "correct": false
        },
        {
          "label": "B",
          "text": "Population genetics",
          "correct": true
        },
        {
          "label": "C",
          "text": "Human genome project",
          "correct": false
        },
        {
          "label": "D",
          "text": "Eugenics",
          "correct": false
        }
      ],
      "correct_answer": "B. Population genetics",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Population genetics</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Gene Therapy: Introduction of a gene sequence into a cell to modify its behaviour .</li><li>\u2022 Option A. Gene Therapy:</li><li>\u2022 Introduction</li><li>\u2022 gene sequence</li><li>\u2022 cell to modify</li><li>\u2022 behaviour</li><li>\u2022 Option C. Human Genome Project: It is an international scientific research project . Primary goals are to determine the sequence of chemical base pairs that make up DNA and to identify the approximately 25,000 genes of the human genome.</li><li>\u2022 Option C. Human Genome Project:</li><li>\u2022 international scientific research project</li><li>\u2022 Option D. Eugenics (Sir Francis Galton): Is a social philosophy which advocates the improvement of human hereditary traits through various forms of intervention (GENETIC MANIPULATION)</li><li>\u2022 Option D. Eugenics (Sir Francis Galton):</li><li>\u2022 social philosophy</li><li>\u2022 advocates the improvement</li><li>\u2022 human hereditary traits</li><li>\u2022 Negative Eugenics: Is aimed at lowering fertility among the genetically disadvantaged (through abortions, Sterilizations and other methods of family planning)</li><li>\u2022 Negative Eugenics:</li><li>\u2022 lowering fertility</li><li>\u2022 genetically disadvantaged</li><li>\u2022 Positive Eugenics: Is aimed to encourage reproduction among the genetically advantaged (through financial and political stimuli, \u200btargeted demographic analyses, in vitro fertilization, egg transplants, gene cloning, etc)</li><li>\u2022 Positive Eugenics:</li><li>\u2022 encourage reproduction</li><li>\u2022 genetically advantaged</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Population genetics focuses on the study of genetic variation and the changes in allele and gene frequencies within populations over time .</li><li>\u27a4 Population genetics</li><li>\u27a4 study of genetic variation</li><li>\u27a4 changes in allele</li><li>\u27a4 gene frequencies</li><li>\u27a4 populations over time</li></ul>\n<p><strong>References:</strong></p><ul><li>\u21b3 Reference:  Park 26 th edition- page 922</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c0256f52",
      "audio": ""
    },
    {
      "text": "A geneticist is giving a presentation on recent advances in the field of genetics. During her talk, she mentions a groundbreaking Human Genome Project, which would subsequently pave the way for advances in many medical and biological fields. What was the primary intention of the project she is referring to?",
      "options": [
        {
          "label": "A",
          "text": "Development of new diagnostic techniques.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Confirming hardy Weinberg law.",
          "correct": false
        },
        {
          "label": "C",
          "text": "Identify genes and sequences of base pair in DNA of human genome.",
          "correct": true
        },
        {
          "label": "D",
          "text": "Introducing gene sequence into a cell to modify its behaviour.",
          "correct": false
        }
      ],
      "correct_answer": "C. Identify genes and sequences of base pair in DNA of human genome.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Identify genes and sequences of base pair in DNA of human genome.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Development of new diagnostic techniques: While the HGP has certainly contributed to the development of new diagnostic techniques , this was not its primary intention.</li><li>\u2022 Option A. Development of new diagnostic techniques:</li><li>\u2022 HGP</li><li>\u2022 contributed</li><li>\u2022 development of new diagnostic techniques</li><li>\u2022 Option B. Confirming the Hardy-Weinberg law: The HGP was not aimed at confirming genetic laws such as the Hardy-Weinberg law but rather at mapping the human genome.</li><li>\u2022 Option B. Confirming the Hardy-Weinberg law:</li><li>\u2022 HGP</li><li>\u2022 not aimed at confirming genetic laws</li><li>\u2022 Option D. Introducing gene sequences into a cell to modify its behavior: This refers to gene therapy , which is a different field and was not the primary goal of the HGP.</li><li>\u2022 Option D. Introducing gene sequences into a cell to modify its behavior:</li><li>\u2022 gene therapy</li><li>\u2022 different field</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The Human Genome Project (HGP) was an international research effort with the primary goal of mapping and understanding all the genes of the human genome .</li><li>\u27a4 Human Genome Project</li><li>\u27a4 international research</li><li>\u27a4 primary goal</li><li>\u27a4 mapping</li><li>\u27a4 genes of the human genome</li></ul>\n<p><strong>References:</strong></p><ul><li>\u21b3 Reference: Park 26 th edition- page 921</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "04abab8f",
      "audio": ""
    },
    {
      "text": "A pediatrician is consulting with a couple who have a family history of phenylketonuria (PKU). They recently had a child and are concerned about the potential for their child to develop PKU symptoms. The doctor explains that while genetic predisposition plays a role, environmental factors such as diet can influence the expression of certain genes. By ensuring that the child adheres to a diet low in phenylalanine, symptoms of PKU can be prevented. This strategy of influencing genetic expression through environmental changes is best described as what?",
      "options": [
        {
          "label": "A",
          "text": "Eugenics",
          "correct": false
        },
        {
          "label": "B",
          "text": "Euthenics",
          "correct": true
        },
        {
          "label": "C",
          "text": "Genetic counselling",
          "correct": false
        },
        {
          "label": "D",
          "text": "Environmental sampling",
          "correct": false
        }
      ],
      "correct_answer": "B. Euthenics",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Euthenics</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Eugenics (Sir Francis Galton): Is a social philosophy which advocates the improvement of human hereditary traits through various forms of intervention (GENETIC MANIPULATION).</li><li>\u2022 Option A. Eugenics (Sir Francis Galton):</li><li>\u2022 social philosophy</li><li>\u2022 advocates</li><li>\u2022 improvement of human hereditary traits</li><li>\u2022 forms of intervention</li><li>\u2022 Negative Eugenics: Is aimed at lowering fertility among the genetically disadvantaged (through Abortions, family planning methods)</li><li>\u2022 Negative Eugenics:</li><li>\u2022 lowering fertility</li><li>\u2022 genetically disadvantaged</li><li>\u2022 Positive Eugenics: Is aimed to encourage reproduction among the genetically advantaged (through financial and political stimuli, targeted demographic analyses, in-vitro fertilization, egg transplants, gene cloning, etc)</li><li>\u2022 Positive Eugenics:</li><li>\u2022 aimed to encourage reproduction</li><li>\u2022 genetically advantaged</li><li>\u2022 Option C. Genetic counselling is a process in which genetic counsellors provide information and support to individuals and families who may be at risk for or affected by genetic disorders . These counsellors are typically trained in medical genetics and counselling techniques and work closely with healthcare providers to assist individuals in understanding the genetic aspects of their health and family history.</li><li>\u2022 Option C. Genetic counselling</li><li>\u2022 process in which genetic counsellors</li><li>\u2022 information</li><li>\u2022 support to individuals</li><li>\u2022 families</li><li>\u2022 affected by genetic disorders</li><li>\u2022 counsellors</li><li>\u2022 trained in medical genetics</li><li>\u2022 counselling techniques</li><li>\u2022 work closely</li><li>\u2022 healthcare providers</li><li>\u2022 Option D. Environmental sampling is a process of collecting and analysing samples from the environment to assess the presence of various substances , pollutants , microorganisms , or other factors . It is an essential practice in environmental monitoring , research , and public health , as it helps identify potential hazards, pollution sources, or changes in the environment over time. Environmental sampling can be applied in various settings, including industrial sites, natural habitats, bodies of water, air quality monitoring, and indoor environments.</li><li>\u2022 Option D. Environmental sampling</li><li>\u2022 process of collecting</li><li>\u2022 analysing samples</li><li>\u2022 environment to assess the presence</li><li>\u2022 various substances</li><li>\u2022 pollutants</li><li>\u2022 microorganisms</li><li>\u2022 other factors</li><li>\u2022 essential practice</li><li>\u2022 environmental monitoring</li><li>\u2022 research</li><li>\u2022 public health</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Euthenics refers to the improvement of human functioning and well-being by altering the environment . It emphasizes the role of environmental factors in the expression of genetic potential .</li><li>\u27a4 Euthenics</li><li>\u27a4 improvement of human functioning</li><li>\u27a4 well-being</li><li>\u27a4 altering the environment</li><li>\u27a4 emphasizes</li><li>\u27a4 role of environmental factors</li><li>\u27a4 expression of genetic potential</li><li>\u27a4 Euthenics is a pre-requisite for Eugenics . Dysgenics is a term describing the progressive evolutionary \u2018weakening\u2019 or genetic deterioration of a population of organisms relative to their environment.</li><li>\u27a4 Euthenics</li><li>\u27a4 pre-requisite for Eugenics</li><li>\u27a4 Dysgenics</li><li>\u27a4 progressive evolutionary \u2018weakening\u2019</li><li>\u27a4 genetic deterioration</li><li>\u27a4 population of organisms</li></ul>\n<p><strong>References:</strong></p><ul><li>\u21b3 Reference: Park 26 th edition- page 922</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "cb9d1f9a",
      "audio": ""
    },
    {
      "text": "A 30-year-old man comes to the clinic with concerns about the possibility of inheriting a genetic condition that has affected several members of his family. Upon obtaining a detailed family history, the physician notes that affected individuals in every generation are both male and female and are often born to unaffected parents. Most of these aconditions follow an autosomal dominant inheritance pattern. Which of the following conditions is NOT typically associated with autosomal dominant inheritance?",
      "options": [
        {
          "label": "A",
          "text": "Neurofibromatosis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Retinoblastoma",
          "correct": false
        },
        {
          "label": "C",
          "text": "Ataxia telangiectasia",
          "correct": true
        },
        {
          "label": "D",
          "text": "Marfan\u2019s syndrome",
          "correct": false
        }
      ],
      "correct_answer": "C. Ataxia telangiectasia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Ataxia telangiectasia</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Neurofibromatosis: This condition follows an autosomal dominant pattern of inheritance . Mutations in the NF1 or NF2 genes are responsible for the different types of neurofibromatosis.</li><li>\u2022 Option A. Neurofibromatosis:</li><li>\u2022 autosomal dominant pattern</li><li>\u2022 inheritance</li><li>\u2022 Option B. Retinoblastoma: This is a cancer of the retina associated with mutations in the RB1 gene . It can be inherited in an autosomal dominant manner.</li><li>\u2022 Option B. Retinoblastoma:</li><li>\u2022 cancer of the retina</li><li>\u2022 mutations in the RB1 gene</li><li>\u2022 Option D. Marfan\u2019s syndrome: Marfan\u2019s syndrome is an autosomal dominant disorder caused by mutations in the FBN1 gene , affecting connective tissues.</li><li>\u2022 Option D. Marfan\u2019s syndrome:</li><li>\u2022 autosomal dominant disorder</li><li>\u2022 mutations in the FBN1 gene</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Autosomal dominant traits</li><li>\u27a4 Autosomal dominant traits</li><li>\u27a4 Achondroplasia Huntington\u2019s chorea Neurofibromatosis Polyposis coli, familial Brachydactyly Marfan\u2019s syndrome Retinoblastoma ABO blood group system Hyperlipoproteinemia I, II, III, IV Polycystic, kidney Polydactyly Spherocytosis, hereditary</li><li>\u27a4 Achondroplasia</li><li>\u27a4 Huntington\u2019s chorea</li><li>\u27a4 Neurofibromatosis</li><li>\u27a4 Polyposis coli, familial</li><li>\u27a4 Brachydactyly</li><li>\u27a4 Marfan\u2019s syndrome</li><li>\u27a4 Retinoblastoma</li><li>\u27a4 ABO blood group system</li><li>\u27a4 Hyperlipoproteinemia I, II, III, IV</li><li>\u27a4 Polycystic, kidney</li><li>\u27a4 Polydactyly Spherocytosis, hereditary</li></ul>\n<p><strong>References:</strong></p><ul><li>\u21b3 Reference: Park 26 th edition- page 918</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f229baf0",
      "audio": ""
    },
    {
      "text": "A 25-year-old woman and a 27-year-old man, both from the same small community, are planning to get married. They seek premarital counseling due to concerns about potential genetic risks for their offspring, as both of them have a family history of the same genetic disorder, although neither of them shows symptoms. The counselor recommends a specific screening process to help assess the risk to their potential offspring. What is this preventive approach called?",
      "options": [
        {
          "label": "A",
          "text": "Mass health education",
          "correct": false
        },
        {
          "label": "B",
          "text": "Legislation",
          "correct": false
        },
        {
          "label": "C",
          "text": "Prospective genetic counselling",
          "correct": true
        },
        {
          "label": "D",
          "text": "Retrospective genetic counselling",
          "correct": false
        }
      ],
      "correct_answer": "C. Prospective genetic counselling",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Prospective genetic counselling</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Mass health education: While important for general public health awareness , mass health education is not specific to assessing individual genetic risks for prospective offspring .</li><li>\u2022 Option A. Mass health education:</li><li>\u2022 general public health awareness</li><li>\u2022 mass health education</li><li>\u2022 not</li><li>\u2022 assessing</li><li>\u2022 genetic risks</li><li>\u2022 prospective offspring</li><li>\u2022 Option B. Legislation: This refers to laws and regulations , which is not relevant to the individualized assessment of genetic risk in a clinical setting.</li><li>\u2022 Option B. Legislation:</li><li>\u2022 laws and regulations</li><li>\u2022 Option D. Retrospective genetic counseling: Seeking genetic advice after a hereditary disorder has already occurred in the family . This is useful in diseases like Congenital anomalies, Mental retardation, Psychiatric illness, Inborn errors of metabolism, etc</li><li>\u2022 Option D. Retrospective genetic counseling:</li><li>\u2022 Seeking genetic advice</li><li>\u2022 hereditary disorder</li><li>\u2022 occurred in the family</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Prospective genetic counseling: Identify heterozygous individuals for any particular defect (through screening) and explain to them the risk of having affected children , if they marry another heterozygote for the same gene . This is useful in diseases like Thalassemia, sickle cell anemia, etc</li><li>\u27a4 Prospective genetic counseling:</li><li>\u27a4 heterozygous individuals</li><li>\u27a4 particular defect</li><li>\u27a4 risk of having affected children</li><li>\u27a4 marry</li><li>\u27a4 heterozygote for the same gene</li></ul>\n<p><strong>References:</strong></p><ul><li>\u21b3 Reference: Park 26 th edition- page 923</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b6a4db83",
      "audio": ""
    },
    {
      "text": "In a global health lecture, the topic of smallpox eradication is discussed, highlighting one of the major public health achievements of the 20th century. The eradication of smallpox was declared at different times in various countries. A medical student interested in the history of infectious diseases asks about the year in which India, a country with a large population and diverse geographic regions, was declared smallpox-free. In which year was India officially declared free of smallpox?",
      "options": [
        {
          "label": "A",
          "text": "May 1975",
          "correct": false
        },
        {
          "label": "B",
          "text": "April 1977",
          "correct": true
        },
        {
          "label": "C",
          "text": "August 1979",
          "correct": false
        },
        {
          "label": "D",
          "text": "May 1980",
          "correct": false
        }
      ],
      "correct_answer": "B. April 1977",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. April 1977</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 The last known case of smallpox in India occurred on 24th May 1975 . India was declared smallpox free on 5th July 1975 .</li><li>\u2022 last known case of smallpox</li><li>\u2022 24th May 1975</li><li>\u2022 India</li><li>\u2022 smallpox free on 5th July 1975</li><li>\u2022 Epidemiological reasons/basis for Smallpox eradication:</li><li>\u2022 Epidemiological reasons/basis for Smallpox eradication:</li><li>\u2022 No known animal reservoir</li><li>\u2022 No</li><li>\u2022 animal reservoir</li><li>\u2022 No long term carrier state</li><li>\u2022 No long term carrier state</li><li>\u2022 Infection provides lifelong immunity</li><li>\u2022 Infection</li><li>\u2022 lifelong immunity</li><li>\u2022 Case detection simple due to characteristic rash</li><li>\u2022 Case detection simple</li><li>\u2022 rash</li><li>\u2022 Subclinical cases did not transmit the disease</li><li>\u2022 Subclinical cases</li><li>\u2022 not transmit</li><li>\u2022 disease</li><li>\u2022 A highly effective vaccine was available</li><li>\u2022 highly effective vaccine</li><li>\u2022 International cooperation</li><li>\u2022 Important Pointers about Small Pox -</li><li>\u2022 Important Pointers about Small Pox -</li><li>\u2022 Last indigenous case of Small pox in India: 17th May 1975 Last [importation] case of Small pox in India: 24th May 1975 India declared Small pox-free : 23 April, 1977 Last case of Small pox globally : 26th October 1977 ( Somalia ) Actual last case of small pox [ Laboratory accident ]: 1978 Global eradication of Small pox: 8th May 1980</li><li>\u2022 Last indigenous case of Small pox in India: 17th May 1975</li><li>\u2022 Last indigenous</li><li>\u2022 Small pox</li><li>\u2022 17th May 1975</li><li>\u2022 Last [importation] case of Small pox in India: 24th May 1975</li><li>\u2022 Last</li><li>\u2022 case of Small pox</li><li>\u2022 24th May 1975</li><li>\u2022 India declared Small pox-free : 23 April, 1977</li><li>\u2022 India</li><li>\u2022 Small pox-free</li><li>\u2022 23 April, 1977</li><li>\u2022 Last case of Small pox globally : 26th October 1977 ( Somalia )</li><li>\u2022 Last case</li><li>\u2022 Small pox</li><li>\u2022 globally</li><li>\u2022 26th October 1977</li><li>\u2022 Somalia</li><li>\u2022 Actual last case of small pox [ Laboratory accident ]: 1978</li><li>\u2022 last case</li><li>\u2022 Laboratory accident</li><li>\u2022 1978</li><li>\u2022 Global eradication of Small pox: 8th May 1980</li><li>\u2022 Global eradication of Small pox: 8th May 1980</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 India was declared small pox free on - 23 April, 1977</li><li>\u27a4 India</li><li>\u27a4 declared small pox free</li><li>\u27a4 23 April, 1977</li><li>\u27a4 Global eradication of Small pox : 8th May 1980</li><li>\u27a4 Global eradication</li><li>\u27a4 Small pox</li><li>\u27a4 8th May 1980</li><li>\u27a4 Ref : Park 26 th edition (page 158)</li><li>\u27a4 Ref : Park 26 th edition (page 158)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "5a605cec",
      "audio": ""
    },
    {
      "text": "During an infectious disease rotation, a medical resident is learning about varicella (chickenpox), a highly contagious infection caused by the varicella-zoster virus. The resident is tasked with assessing the risk of transmission within households and communities. A key concept in understanding the spread of chickenpox is the secondary attack rate, which measures the likelihood of the disease spreading to susceptible individuals after exposure to a primary case. What is the secondary attack rate typically associated with chickenpox?",
      "options": [
        {
          "label": "A",
          "text": "60%",
          "correct": false
        },
        {
          "label": "B",
          "text": "45%",
          "correct": false
        },
        {
          "label": "C",
          "text": "25%",
          "correct": false
        },
        {
          "label": "D",
          "text": "90%",
          "correct": true
        }
      ],
      "correct_answer": "D. 90%",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/08/screenshot-2024-08-08-161226.png"
      ],
      "explanation": "<p><strong>Ans. D. 90%</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 SAR is approximately 90 % in susceptible household contacts of chicken pox case .</li><li>\u2022 SAR</li><li>\u2022 90 %</li><li>\u2022 susceptible household contacts</li><li>\u2022 chicken pox case</li><li>\u2022 Secondary Attack Rate (SAR): Is no. of exposed persons developing the disease within range of incubation period , following exposure to the primary case . The denominator includes only those susceptible to disease . The primary case is always excluded both from numerator and denominator for SAR calculation.</li><li>\u2022 Secondary Attack Rate (SAR):</li><li>\u2022 no. of exposed persons</li><li>\u2022 disease</li><li>\u2022 incubation period</li><li>\u2022 exposure</li><li>\u2022 primary case</li><li>\u2022 denominator</li><li>\u2022 susceptible to disease</li><li>\u2022 primary</li><li>\u2022 excluded</li><li>\u2022 numerator and denominator</li><li>\u2022 SAR calculation.</li><li>\u2022 Secondary attack rate of some important diseases are -</li><li>\u2022 Secondary attack rate of some important diseases are -</li><li>\u2022 \u200b\u200b\u200b\u200b\u200b        \u200b\u200b\u200b\u200b\u200b</li><li>\u2022 Chickenpox -</li><li>\u2022 Chickenpox -</li><li>\u2022 Period of Communicability/ infectivity - 1\u20132 days before to 4\u20135 days after appearance of rash . Incubation Period - 14-16 days Rash - Chickenpox rash - Dew drop on rose petal appearance Centripetal distribution, Pleomorphic rash</li><li>\u2022 Period of Communicability/ infectivity - 1\u20132 days before to 4\u20135 days after appearance of rash .</li><li>\u2022 Communicability/ infectivity</li><li>\u2022 1\u20132 days before</li><li>\u2022 4\u20135 days after</li><li>\u2022 rash</li><li>\u2022 Incubation Period - 14-16 days</li><li>\u2022 Incubation Period</li><li>\u2022 14-16</li><li>\u2022 Rash - Chickenpox rash - Dew drop on rose petal appearance Centripetal distribution, Pleomorphic rash</li><li>\u2022 Chickenpox rash</li><li>\u2022 Dew drop</li><li>\u2022 rose petal</li><li>\u2022 Centripetal</li><li>\u2022 Pleomorphic</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The secondary attack rate of Chickenpox is - 90%</li><li>\u27a4 secondary attack rate</li><li>\u27a4 Chickenpox</li><li>\u27a4 90%</li><li>\u27a4 Ref : Park 26 th edition (page 159)</li><li>\u27a4 Ref : Park 26 th edition (page 159)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2bb37f98",
      "audio": ""
    },
    {
      "text": "A medical resident treating a patient with chickenpox is discussing the case with a senior colleague. They talk about the infectious period of chickenpox, which is important for implementing appropriate isolation measures and preventing the spread of the infection. The resident is asked to identify the typical period during which a patient with chickenpox is infectious to others. When is the period of infectivity in a case of chickenpox?",
      "options": [
        {
          "label": "A",
          "text": "1 to 2 days before rash and 4 to 5 days thereafter",
          "correct": true
        },
        {
          "label": "B",
          "text": "4 to 5 days before rash and 1 to 2 days thereafter",
          "correct": false
        },
        {
          "label": "C",
          "text": "3 to 4 days before rash and 4 to 5 days thereafter",
          "correct": false
        },
        {
          "label": "D",
          "text": "1 day before rash and 2 days thereafter",
          "correct": false
        }
      ],
      "correct_answer": "A. 1 to 2 days before rash and 4 to 5 days thereafter",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. 1 to 2 days before rash and 4 to 5 days thereafter</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 The period of communicability of patients with varicella is estimated to range from 1 to 2 days before the appearance of rash , and 4 to 5 days thereafter. The virus tends to die out before the pustular stage . The patient ceases to be infectious once the lesions have crusted.</li><li>\u2022 period of communicability</li><li>\u2022 varicella</li><li>\u2022 1 to 2 days</li><li>\u2022 before</li><li>\u2022 rash</li><li>\u2022 4 to 5 days</li><li>\u2022 virus</li><li>\u2022 die</li><li>\u2022 before</li><li>\u2022 pustular stage</li><li>\u2022 patient ceases</li><li>\u2022 infectious</li><li>\u2022 lesions</li><li>\u2022 crusted.</li><li>\u2022 Some important Pointers -</li><li>\u2022 Some important Pointers -</li><li>\u2022 Chicken pox rash - Dew drop on rose petal appearance; Centripetal distribution ; Pleomorphic rash False about chickenpox is - Crusts contain live virus Chickenpox Synonym : \u2018Varicella\u2019 Causative agent: Varicella zoster virus [Human (alpha) Herpes Virus\u20133 ] Incubation period: 14\u201316 days Source of infection: Case ( person-to-person contact ) Mode of transmission : Air droplets (respiratory) Secondary Attack rate : 90%MC late complication of chickenpox : Shingles (caused by reactivation of the virus decades after the initial episode of chickenpox ) Most rapid and sensitive means of diagnosis: Examination of vesicle fluid under electron microscope (shows round particles) Congenital Varicella: Most threatening if transmitted in 1 st trimester of pregnancy Live attenuated Chickenpox Monovalent Vaccine Strain - OKA strain</li><li>\u2022 Chicken pox rash - Dew drop on rose petal appearance; Centripetal distribution ; Pleomorphic rash</li><li>\u2022 Dew drop</li><li>\u2022 rose petal</li><li>\u2022 Centripetal distribution</li><li>\u2022 Pleomorphic rash</li><li>\u2022 False about chickenpox is - Crusts contain live virus</li><li>\u2022 False</li><li>\u2022 Crusts</li><li>\u2022 live virus</li><li>\u2022 Chickenpox Synonym : \u2018Varicella\u2019</li><li>\u2022 Synonym</li><li>\u2022 \u2018Varicella\u2019</li><li>\u2022 Causative agent: Varicella zoster virus [Human (alpha) Herpes Virus\u20133 ]</li><li>\u2022 Varicella zoster virus</li><li>\u2022 Herpes Virus\u20133</li><li>\u2022 Incubation period: 14\u201316 days</li><li>\u2022 14\u201316 days</li><li>\u2022 Source of infection: Case ( person-to-person contact )</li><li>\u2022 person-to-person contact</li><li>\u2022 Mode of transmission : Air droplets (respiratory)</li><li>\u2022 Mode</li><li>\u2022 transmission</li><li>\u2022 Air droplets</li><li>\u2022 Secondary Attack rate : 90%MC late complication of chickenpox : Shingles (caused by reactivation of the virus decades after the initial episode of chickenpox )</li><li>\u2022 Secondary Attack rate</li><li>\u2022 90%MC</li><li>\u2022 chickenpox</li><li>\u2022 Shingles</li><li>\u2022 reactivation</li><li>\u2022 virus decades</li><li>\u2022 initial episode of chickenpox</li><li>\u2022 Most rapid and sensitive means of diagnosis: Examination of vesicle fluid under electron microscope (shows round particles)</li><li>\u2022 rapid and sensitive</li><li>\u2022 vesicle fluid</li><li>\u2022 electron microscope</li><li>\u2022 Congenital Varicella: Most threatening if transmitted in 1 st trimester of pregnancy</li><li>\u2022 Most threatening</li><li>\u2022 1 st</li><li>\u2022 trimester</li><li>\u2022 pregnancy</li><li>\u2022 Live attenuated Chickenpox Monovalent Vaccine Strain - OKA strain</li><li>\u2022 Live attenuated Chickenpox Monovalent Vaccine Strain</li><li>\u2022 OKA</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The period of infectivity in a case of Chickenpox - 1 to 2 days before rash and 4 to 5 days thereafter.</li><li>\u27a4 period of infectivity</li><li>\u27a4 Chickenpox</li><li>\u27a4 1 to 2 days before</li><li>\u27a4 rash</li><li>\u27a4 4 to 5 days thereafter.</li><li>\u27a4 Ref : Park 26 th edition (page 159)</li><li>\u27a4 Ref : Park 26 th edition (page 159)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c7a696ff",
      "audio": ""
    },
    {
      "text": "A pediatric resident is evaluating a child at a Community Health Center (CHC) who presents with fever and a distinctive rash. Upon examination, the resident notes the simultaneous presence of papules, vesicles, and crusts all in the same area of the skin. This combination of lesions at different stages of development in the same area is characteristic of a specific viral infection. What is the most probable diagnosis for this child?",
      "options": [
        {
          "label": "A",
          "text": "Small pox",
          "correct": false
        },
        {
          "label": "B",
          "text": "Measles",
          "correct": false
        },
        {
          "label": "C",
          "text": "Dengue",
          "correct": false
        },
        {
          "label": "D",
          "text": "Chickenpox",
          "correct": true
        }
      ],
      "correct_answer": "D. Chickenpox",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/18/image_4PQz4JP.png"
      ],
      "explanation_images": [
        "https://my.clevelandclinic.org/-/scassets/images/org/health/articles/10855-smallpox",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/28/image-20231128145356-1.jpeg",
        "https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcRj7uaO9jM9z0k4dHy9_lFnLS9eMRr-Nksglw&usqp=CAU",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/12/picture11_HrNvuDK.jpg"
      ],
      "explanation": "<p><strong>Ans. D. Chickenpox</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Small pox: smallpox lesions appear in the same stage of development at the same time all over the body ( non pleomorphic ), unlike chickenpox where different stages are seen in the same area.</li><li>\u2022 Option</li><li>\u2022 A. Small pox:</li><li>\u2022 smallpox lesions</li><li>\u2022 same stage of development</li><li>\u2022 same time</li><li>\u2022 non pleomorphic</li><li>\u2022 unlike chickenpox</li><li>\u2022 different stages</li><li>\u2022 seen</li><li>\u2022 same area.</li><li>\u2022 Option B. Measles: Maculopapular rash that typically begins on the face and spreads downward . It does not present with lesions at different stages (papules, vesicles, crusts) in the same area.</li><li>\u2022 Option B. Measles:</li><li>\u2022 Maculopapular rash</li><li>\u2022 begins</li><li>\u2022 face and spreads downward</li><li>\u2022 not</li><li>\u2022 lesions at different stages</li><li>\u2022 same area.</li><li>\u2022 Option C. Dengue: Dengue fever can present with a rash, but it is usually a diffuse erythematous rash , not one with papules, vesicles, and crusts in the same area.</li><li>\u2022 Option C. Dengue:</li><li>\u2022 Dengue fever</li><li>\u2022 rash,</li><li>\u2022 diffuse erythematous rash</li><li>\u2022 not</li><li>\u2022 papules, vesicles, and crusts</li><li>\u2022 same area.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Chickenpox rash - Dew drop on rose petal appearance ; Centripetal distribution; Pleomorphic rash.</li><li>\u27a4 Chickenpox rash</li><li>\u27a4 Dew drop</li><li>\u27a4 rose</li><li>\u27a4 petal appearance</li><li>\u27a4 Centripetal distribution; Pleomorphic rash.</li><li>\u27a4 Difference between Chicken Pox and Small Pox rash</li><li>\u27a4 Difference between Chicken Pox and Small Pox rash</li><li>\u27a4 Ref : Park 26 th edition (page 159)</li><li>\u27a4 Ref : Park 26 th edition (page 159)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8f8eaae5",
      "audio": ""
    },
    {
      "text": "A medical resident is discussing the administration of the measles vaccine with a supervising physician. The conversation focuses on contraindications to vaccination, which are critical for ensuring patient safety. The resident is asked about definitive contraindications for administering the measles vaccine. Which of the following is considered a definitive contraindication for the measles vaccine?",
      "options": [
        {
          "label": "A",
          "text": "Pregnancy",
          "correct": true
        },
        {
          "label": "B",
          "text": "HIV infection- asymptomatic",
          "correct": false
        },
        {
          "label": "C",
          "text": "Respiratory infection",
          "correct": false
        },
        {
          "label": "D",
          "text": "Malnutrition",
          "correct": false
        }
      ],
      "correct_answer": "A. Pregnancy",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Pregnancy</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. HIV Infection - Asymptomatic: Can be administered to HIV-infected individuals , especially if they are asymptomatic or not severely immunocompromised . Vaccination should be considered after careful evaluation of the immune status.</li><li>\u2022 Option B. HIV Infection - Asymptomatic:</li><li>\u2022 administered to HIV-infected individuals</li><li>\u2022 asymptomatic</li><li>\u2022 not severely immunocompromised</li><li>\u2022 Vaccination</li><li>\u2022 considered</li><li>\u2022 evaluation of the immune status.</li><li>\u2022 Option C. Respiratory Infection: Not a contraindication, if the illness is mild and without fever , vaccination can generally proceed .</li><li>\u2022 Option C. Respiratory Infection: Not</li><li>\u2022 contraindication,</li><li>\u2022 illness is mild</li><li>\u2022 without fever</li><li>\u2022 proceed</li><li>\u2022 Option D. Malnutrition: Malnutrition , particularly in countries where measles is endemic , is not a contraindication to measles vaccination. In fact, vaccination is crucial in malnourished individuals due to their increased risk of severe measles .</li><li>\u2022 Option D. Malnutrition:</li><li>\u2022 ,</li><li>\u2022 measles is endemic</li><li>\u2022 not</li><li>\u2022 contraindication</li><li>\u2022 measles</li><li>\u2022 vaccination</li><li>\u2022 malnourished</li><li>\u2022 increased risk</li><li>\u2022 severe measles</li><li>\u2022 Some important pointers regarding vaccine contraindications -</li><li>\u2022 Vaccines contraindicated in Pregnancy : All live vaccines EXCEPT Yellow fever vaccine Vaccines contraindicated in HIV : Asymptomatic HIV: NONE Symptomatic HIV : All live vaccines EXCEPT MMR, Varicella & Zoster may be given if required Vaccines contraindicated in Immuno-suppression: All live vaccines Vaccines contraindicated in Corticosteroid therapy: All live vaccines Vaccines contraindicated in fever : Typhoid vaccines Vaccines contraindicated in ARTI/diarrhoea: NONE Vaccines contraindicated together: Yellow fever and Cholera vaccine Vaccine contraindicated in Preterm-premature baby with birth weight < 2 kg: Hepatitis B Vaccines contraindicated in age < 1 year (infants): \u2013 Yellow fever vaccine, Meningococcal vaccine, Pneumococcal vaccine Vaccines contraindicated in age < 2 year (infants): \u2013 Meningococcal vaccine, Pneumococcal vaccine, Typhoid vaccines Vaccine contraindicated in progressive neurological disease : Pertussis vaccine (Pertussis vaccine IS NOT CONTRAINDICATED IN epilepsy controlled on medications, Cerebral palsy) Only absolute contraindication to killed vaccines : Severe local or general reaction to a previous dose</li><li>\u2022 Vaccines contraindicated in Pregnancy : All live vaccines EXCEPT Yellow fever vaccine</li><li>\u2022 contraindicated</li><li>\u2022 Pregnancy</li><li>\u2022 EXCEPT Yellow fever vaccine</li><li>\u2022 Vaccines contraindicated in HIV : Asymptomatic HIV: NONE Symptomatic HIV : All live vaccines EXCEPT MMR, Varicella & Zoster may be given if required</li><li>\u2022 contraindicated</li><li>\u2022 HIV</li><li>\u2022 Asymptomatic HIV: NONE Symptomatic HIV : All live vaccines EXCEPT MMR, Varicella & Zoster may be given if required</li><li>\u2022 Asymptomatic HIV: NONE</li><li>\u2022 Symptomatic HIV : All live vaccines EXCEPT MMR, Varicella & Zoster may be given if required</li><li>\u2022 Symptomatic HIV</li><li>\u2022 All live vaccines</li><li>\u2022 MMR, Varicella & Zoster</li><li>\u2022 Vaccines contraindicated in Immuno-suppression: All live vaccines</li><li>\u2022 Vaccines contraindicated in Corticosteroid therapy: All live vaccines</li><li>\u2022 Vaccines contraindicated in fever : Typhoid vaccines</li><li>\u2022 contraindicated</li><li>\u2022 fever</li><li>\u2022 Typhoid vaccines</li><li>\u2022 Vaccines contraindicated in ARTI/diarrhoea: NONE</li><li>\u2022 Vaccines contraindicated together: Yellow fever and Cholera vaccine</li><li>\u2022 Vaccine contraindicated in Preterm-premature baby with birth weight < 2 kg: Hepatitis B</li><li>\u2022 Preterm-premature baby</li><li>\u2022 Hepatitis B</li><li>\u2022 Vaccines contraindicated in age < 1 year (infants): \u2013 Yellow fever vaccine, Meningococcal vaccine, Pneumococcal vaccine</li><li>\u2022 Vaccines contraindicated in age < 2 year (infants): \u2013 Meningococcal vaccine, Pneumococcal vaccine, Typhoid vaccines</li><li>\u2022 Vaccine contraindicated in progressive neurological disease : Pertussis vaccine (Pertussis vaccine IS NOT CONTRAINDICATED IN epilepsy controlled on medications, Cerebral palsy)</li><li>\u2022 contraindicated</li><li>\u2022 progressive neurological disease</li><li>\u2022 Pertussis vaccine</li><li>\u2022 Only absolute contraindication to killed vaccines : Severe local or general reaction to a previous dose</li><li>\u2022 absolute contraindication</li><li>\u2022 killed vaccines</li><li>\u2022 local or general reaction</li><li>\u2022 previous dose</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Measles vaccine is definitively contraindicated in pregnancy.</li><li>\u27a4 Measles vaccine</li><li>\u27a4 definitively</li><li>\u27a4 contraindicated</li><li>\u27a4 pregnancy.</li><li>\u27a4 Ref : Textbook of Community Medicine- Rajvir Bhalwar- 4 th edition (page 729)</li><li>\u27a4 Ref : Textbook of Community Medicine- Rajvir Bhalwar- 4 th edition (page 729)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "054cedea",
      "audio": ""
    },
    {
      "text": "During a clinical discussion on the management of measles, particularly in high-risk patients or those with contraindications to the measles vaccine, the topic of passive immunization arises. A medical resident is asked about the appropriate dosing of human immunoglobulin for providing passive immunity against measles. Understanding the correct dosage is crucial for effective post-exposure prophylaxis in susceptible individuals. What is the recommended dose of human immunoglobulin for passive immunization against measles?",
      "options": [
        {
          "label": "A",
          "text": "0.15 ml per kg body weight",
          "correct": false
        },
        {
          "label": "B",
          "text": "0.25 ml per kg body weight",
          "correct": true
        },
        {
          "label": "C",
          "text": "0.35 ml per kg body weight",
          "correct": false
        },
        {
          "label": "D",
          "text": "0.45 ml per kg body weight",
          "correct": false
        }
      ],
      "correct_answer": "B. 0.25 ml per kg body weight",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. 0.25 ml per kg body weight</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Measles may be prevented by administration of immunoglobulin (human) early in the incubation period . The dose recommended by WHO is 0.25 ml per kg of body weight should be given within 4 days of exposure.</li><li>\u2022 Measles</li><li>\u2022 prevented</li><li>\u2022 immunoglobulin (human)</li><li>\u2022 incubation period</li><li>\u2022 dose</li><li>\u2022 WHO</li><li>\u2022 0.25 ml</li><li>\u2022 body weight</li><li>\u2022 within 4 days</li><li>\u2022 exposure.</li><li>\u2022 The person passively immunized should be given live vaccine, 8-12 weeks later.</li><li>\u2022 passively immunized</li><li>\u2022 live vaccine, 8-12 weeks</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Dose of human immunoglobulin for providing passive immunity against measles - 0.25 ml per kg of body weight.</li><li>\u27a4 Dose</li><li>\u27a4 human immunoglobulin</li><li>\u27a4 passive immunity</li><li>\u27a4 against</li><li>\u27a4 measles</li><li>\u27a4 0.25 ml</li><li>\u27a4 kg of body weight.</li><li>\u27a4 Ref : Park 26 th edition (page 165)</li><li>\u27a4 Ref : Park 26 th edition (page 165)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2979ca5d",
      "audio": ""
    },
    {
      "text": "During a pediatric infectious disease rotation, a medical student learns about the natural immunity conferred by viral infections. One topic of interest is the immunity that follows an infection with the measles virus. Understanding the duration of immunity after natural infection is important for patient counseling and future vaccination planning. After a patient recovers from an attack of measles, how long does the immunity typically last?",
      "options": [
        {
          "label": "A",
          "text": "5 years",
          "correct": false
        },
        {
          "label": "B",
          "text": "Lifelong",
          "correct": true
        },
        {
          "label": "C",
          "text": "10 years",
          "correct": false
        },
        {
          "label": "D",
          "text": "No immunity",
          "correct": false
        }
      ],
      "correct_answer": "B. Lifelong",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. lifelong</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 No age is immune if there was no previous immunity . One attack of measles generally confers life-long immunity. Second attacks are rare .</li><li>\u2022 No age</li><li>\u2022 immune</li><li>\u2022 no previous immunity</li><li>\u2022 One</li><li>\u2022 measles</li><li>\u2022 life-long immunity.</li><li>\u2022 Second attacks</li><li>\u2022 rare</li><li>\u2022 Other diseases provide lifelong immunity with a single attack - Mumps, Rubella, Yellow fever.</li><li>\u2022 Other diseases</li><li>\u2022 lifelong immunity</li><li>\u2022 single attack</li><li>\u2022 Mumps, Rubella, Yellow fever.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In measles disease , both natural infection and vaccination confer lifelong immunity/protection from infection of measles.</li><li>\u27a4 measles disease</li><li>\u27a4 both</li><li>\u27a4 natural infection and vaccination</li><li>\u27a4 lifelong immunity/protection</li><li>\u27a4 measles.</li><li>\u27a4 Ref : Park 26 th edition (page 162)</li><li>\u27a4 Ref : Park 26 th edition (page 162)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b0ecca69",
      "audio": ""
    },
    {
      "text": "During a public health campaign aimed at increasing vaccination rates, a 30-year-old pediatrician is discussing the rubella vaccine with his interns. He emphasizes the importance of understanding the components of vaccines, including the specific viral strains used, to effectively communicate with the community and address any concerns. He poses a question to his interns about the strain of the virus used in the current rubella vaccines. Which strain of the virus is used in the current rubella vaccines?",
      "options": [
        {
          "label": "A",
          "text": "RA 27/3 strain",
          "correct": true
        },
        {
          "label": "B",
          "text": "Jeryll lynn strain",
          "correct": false
        },
        {
          "label": "C",
          "text": "Edmonston Zagreb strain",
          "correct": false
        },
        {
          "label": "D",
          "text": "17 D strain",
          "correct": false
        }
      ],
      "correct_answer": "A. RA 27/3 strain",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/12/picture13.jpg"
      ],
      "explanation": "<p><strong>Ans. A. RA 27/3 strain</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Jeryll lynn strain - Mumps vaccine</li><li>\u2022 Option B. Jeryll lynn strain</li><li>\u2022 Option C. Edmonston Zagreb strain - Measles vaccine</li><li>\u2022 Option C. Edmonston Zagreb strain</li><li>\u2022 Option D. 17 D strain - Yellow Fever Vaccine</li><li>\u2022 Option D. 17 D strain</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Rubella vaccine strain - RA 27/3</li><li>\u27a4 Rubella</li><li>\u27a4 strain -</li><li>\u27a4 RA 27/3</li><li>\u27a4 Vaccines and different strains :</li><li>\u27a4 Ref: Park 26 th edition (page 167)</li><li>\u27a4 Ref: Park 26 th edition (page 167)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3ab76612",
      "audio": ""
    },
    {
      "text": "During an epidemiology lecture at a medical school, the professor discusses the transmission dynamics of various viral infections. Mumps, a contagious viral infection, is highlighted for its notable secondary attack rate, particularly in settings where close contact occurs, such as schools and family households. A medical student is asked about the secondary attack rate of mumps to understand its transmissibility. What is the secondary attack rate of mumps?",
      "options": [
        {
          "label": "A",
          "text": "26%",
          "correct": false
        },
        {
          "label": "B",
          "text": "66%",
          "correct": false
        },
        {
          "label": "C",
          "text": "86%",
          "correct": true
        },
        {
          "label": "D",
          "text": "100%",
          "correct": false
        }
      ],
      "correct_answer": "C. 86%",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/12/picture14.jpg"
      ],
      "explanation": "<p><strong>Ans. C. 86%</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 The Secondary attack rate for mumps is estimated to be about 86 percent.</li><li>\u2022 Secondary Attack Rate (SAR)</li><li>\u2022 Is no. of exposed persons developing the disease within the range of incubation period (IP), following exposure to the primary case Denominator includes only those susceptible in close contact Primary case is always excluded both from numerator and denominator for SAR calculation</li><li>\u2022 Is no. of exposed persons developing the disease within the range of incubation period (IP), following exposure to the primary case</li><li>\u2022 Denominator includes only those susceptible in close contact</li><li>\u2022 Primary case is always excluded both from numerator and denominator for SAR calculation</li><li>\u2022 Secondary Attack Rate of some diseases</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Secondary attack rate of Mumps - 86% (>85%)</li><li>\u27a4 Infectivity is also termed as Secondary attack rate</li><li>\u27a4 Ref : Park 26 th edition (page 168)</li><li>\u27a4 Ref : Park 26 th edition (page 168)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "214c8e41",
      "audio": ""
    },
    {
      "text": "During an infectious disease rotation, a medical resident is tasked with developing a protocol for managing potential outbreaks of Influenza H1N1 in a hospital setting. As part of the protocol, the resident must consider options for chemoprophylaxis, especially for high-risk patients and healthcare workers who may be exposed to the virus. The resident discusses with the supervising physician about the appropriate medication for chemoprophylaxis against Influenza H1N1. Which medication is recommended for chemoprophylaxis against Influenza H1N1?",
      "options": [
        {
          "label": "A",
          "text": "45 mg OD of Oseltamivir",
          "correct": false
        },
        {
          "label": "B",
          "text": "75 mg OD of Oseltamivir",
          "correct": true
        },
        {
          "label": "C",
          "text": "45 mg OD of Zanamivir",
          "correct": false
        },
        {
          "label": "D",
          "text": "70 mg OD of Zanamivir",
          "correct": false
        }
      ],
      "correct_answer": "B. 75 mg OD of Oseltamivir",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. 75 mg of Oseltamivir</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Oseltamivir (Tamiflu) is the drug of choice for chemoprophylaxis to health care personnel and close contacts of suspected, probable or confirmed case of pandemic influenza A (H1N1) 2009. It should be given till 10 days after last exposure .</li><li>\u2022 Oseltamivir (Tamiflu)</li><li>\u2022 chemoprophylaxis to health care personnel and close contacts</li><li>\u2022 probable or confirmed</li><li>\u2022 pandemic influenza A (H1N1)</li><li>\u2022 10 days after last exposure</li><li>\u2022 For adults above 40 kg the dose is 75 mg OD.</li><li>\u2022 For adults</li><li>\u2022 40 kg</li><li>\u2022 75 mg OD.</li><li>\u2022 H1N1 (Type A) \u2013 Cause of Swine flu</li><li>\u2022 H1N1 (Type A)</li><li>\u2022 Swine flu</li><li>\u2022 Antiviral therapy for H1N1 :</li><li>\u2022 Antiviral</li><li>\u2022 H1N1</li><li>\u2022 Severe/progressive clinical illness: Oseltamivir (if not available or resistant , use Zanamivir ) High risk of severe/complicated illness : Oseltamivir OR Zanamivir Not high risk OR Uncomplicated confirmed/suspected illness: No need of treatment Dosage: Oseltamivir - 75 mg BD \u00d7 5 days (DOC) Zanamivir - 2 inhalations ( 2 \u00d7 5 mg) BD \u00d7 5 days</li><li>\u2022 Severe/progressive clinical illness: Oseltamivir (if not available or resistant , use Zanamivir )</li><li>\u2022 Severe/progressive</li><li>\u2022 Oseltamivir</li><li>\u2022 not available</li><li>\u2022 resistant</li><li>\u2022 Zanamivir</li><li>\u2022 High risk of severe/complicated illness : Oseltamivir OR Zanamivir</li><li>\u2022 High risk</li><li>\u2022 severe/complicated</li><li>\u2022 : Oseltamivir OR Zanamivir</li><li>\u2022 Not high risk OR Uncomplicated confirmed/suspected illness: No need of treatment</li><li>\u2022 Not</li><li>\u2022 Uncomplicated</li><li>\u2022 No</li><li>\u2022 treatment</li><li>\u2022 Dosage: Oseltamivir - 75 mg BD \u00d7 5 days (DOC) Zanamivir - 2 inhalations ( 2 \u00d7 5 mg) BD \u00d7 5 days</li><li>\u2022 Oseltamivir - 75 mg BD \u00d7 5 days (DOC) Zanamivir - 2 inhalations ( 2 \u00d7 5 mg) BD \u00d7 5 days</li><li>\u2022 Oseltamivir - 75 mg BD \u00d7 5 days (DOC)</li><li>\u2022 Oseltamivir</li><li>\u2022 75 mg BD</li><li>\u2022 5 days</li><li>\u2022 Zanamivir - 2 inhalations ( 2 \u00d7 5 mg) BD \u00d7 5 days</li><li>\u2022 Zanamivir</li><li>\u2022 2 inhalations</li><li>\u2022 2 \u00d7 5</li><li>\u2022 BD</li><li>\u2022 5 days</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Chemoprophylaxis against H1N1 - Oseltamivir 75 mg OD till 10 days after last exposure.</li><li>\u27a4 Chemoprophylaxis</li><li>\u27a4 H1N1 - Oseltamivir 75 mg OD</li><li>\u27a4 10 days</li><li>\u27a4 last exposure.</li></ul>\n<p><strong>References:</strong></p><ul><li>\u21b3 Reference: Park 26 th edition (page 175)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "43caa11d",
      "audio": ""
    },
    {
      "text": "A group of individuals presented to a clinic with symptoms of abdominal cramps, diarrhea, and vomiting approximately 2 hours after consuming a milkshake from a local eatery. As a medical resident in gastroenterology, you are tasked with determining the most likely etiological agent responsible for these symptoms. Given the rapid onset of symptoms and the nature of the consumed product, you consider various foodborne pathogens that could be involved. Based on the symptoms and their rapid onset following the consumption of a milkshake, what is the most likely etiological agent responsible for the illness in these individuals?",
      "options": [
        {
          "label": "A",
          "text": "Campylobacter",
          "correct": false
        },
        {
          "label": "B",
          "text": "Clostridium",
          "correct": false
        },
        {
          "label": "C",
          "text": "Salmonella",
          "correct": false
        },
        {
          "label": "D",
          "text": "Staphylococcus",
          "correct": true
        }
      ],
      "correct_answer": "D. Staphylococcus",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/08/screenshot-2024-08-08-123108_XcxG8VU.png",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/08/screenshot-2024-08-08-123453.png"
      ],
      "explanation": "<p><strong>Ans. D. Staphylococcus</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Campylobacter: An infection caused by gram negative bacteria usually from contaminated food and water. Infections are often associated with international travel, undercooked poultry, unpasteurized milk, untreated water, and contact with farm animals . It causes diarrhea which may be bloody, cramping, abdominal pain, and fever within two to five days after exposure to the bacteria . Nausea (a feeling of sickness in the stomach) and vomiting may also occur. The illness typically lasts about one week.</li><li>\u2022 Option A. Campylobacter:</li><li>\u2022 gram negative bacteria</li><li>\u2022 contaminated food and water.</li><li>\u2022 undercooked poultry, unpasteurized milk, untreated</li><li>\u2022 water, and contact</li><li>\u2022 farm animals</li><li>\u2022 diarrhea</li><li>\u2022 bloody,</li><li>\u2022 cramping, abdominal pain, and fever</li><li>\u2022 two to five days</li><li>\u2022 . Nausea</li><li>\u2022 vomiting</li><li>\u2022 lasts</li><li>\u2022 one week.</li><li>\u2022 Option B. Clostridium 2 types:  Botulism food poisoning by Clostridium botulinum type A, B, E ; IP 12\u201336 hours ; food poisoning is due to Intra-dietetic toxins ; prominent symptoms are Dysphagia, Diplopia and Dysarthria (GIT SYMPOTOMS ARE SLIGHT).</li><li>\u2022 Option</li><li>\u2022 B. Clostridium 2 types:  Botulism food poisoning</li><li>\u2022 Clostridium botulinum</li><li>\u2022 A, B, E</li><li>\u2022 IP 12\u201336 hours</li><li>\u2022 Intra-dietetic</li><li>\u2022 toxins</li><li>\u2022 Dysphagia, Diplopia and Dysarthria</li><li>\u2022 Clostridium perfringens food poisoning by Clostridium perfringens (welchii); IP 6\u201324 hours , found on raw meat and poultry , in the soil , excreta . Symptoms are watery diarrhea and abdominal cramps . Rapid recovery with no deaths.</li><li>\u2022 Clostridium perfringens food poisoning</li><li>\u2022 Clostridium perfringens</li><li>\u2022 IP 6\u201324 hours</li><li>\u2022 raw meat and poultry</li><li>\u2022 soil</li><li>\u2022 excreta</li><li>\u2022 watery diarrhea and abdominal cramps</li><li>\u2022 Rapid recovery</li><li>\u2022 no deaths.</li><li>\u2022 Option C. Salmonella: Salmonella bacteria spread by improper handling and cooking of food . Occurs by eating contaminated food such as undercooked pork and poultry meat, dairy products made from unpasteurized milk , chocolate or raw fruit and vegetables . IP 12-24 hr . Some people with salmonella infection have no symptoms . Most people develop diarrhea , fever and stomach (abdominal) cramps within 12 to 72 hours after exposure. Most healthy people recover within a few days to a week without specific treatment.</li><li>\u2022 Option C. Salmonella:</li><li>\u2022 improper handling</li><li>\u2022 cooking of food</li><li>\u2022 eating contaminated food</li><li>\u2022 undercooked pork</li><li>\u2022 poultry meat, dairy products</li><li>\u2022 unpasteurized milk</li><li>\u2022 chocolate</li><li>\u2022 raw fruit and vegetables</li><li>\u2022 12-24 hr</li><li>\u2022 Some people</li><li>\u2022 no symptoms</li><li>\u2022 develop diarrhea</li><li>\u2022 fever and stomach</li><li>\u2022 cramps</li><li>\u2022 12 to 72 hours</li><li>\u2022 healthy</li><li>\u2022 recover within a few days</li><li>\u2022 week</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Incubation period of food poisoning:</li><li>\u27a4 Incubation period of food poisoning:</li><li>\u27a4 Some food poisoning causing organisms</li><li>\u27a4 Some food poisoning causing organisms</li><li>\u27a4 Ref : Park 26 th edition (page 276)</li><li>\u27a4 Ref : Park 26 th edition (page 276)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7f3a544a",
      "audio": ""
    },
    {
      "text": "As part of an epidemiology class focusing on foodborne illnesses, medical students are learning about various pathogens and their associated incubation periods. Understanding these incubation periods is crucial for diagnosing foodborne illnesses and identifying the likely causative agents. The professor has provided a list of common foodborne pathogens and a separate list of their typical incubation periods. The students are asked to match each pathogen with its corresponding incubation period. Task: Match the following pathogens with their respective incubation periods for food poisoning.",
      "options": [
        {
          "label": "A",
          "text": "i- c, ii- b, iii- a, iv-d",
          "correct": true
        },
        {
          "label": "B",
          "text": "i- c, ii- a, iii- b, iv-d",
          "correct": false
        },
        {
          "label": "C",
          "text": "i- d, ii- b, iii- a, iv-c",
          "correct": false
        },
        {
          "label": "D",
          "text": "i- d, ii- a, iii- b, iv-c",
          "correct": false
        }
      ],
      "correct_answer": "A. i- c, ii- b, iii- a, iv-d",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/08/screenshot-2024-08-08-120803.png"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/08/screenshot-2024-08-08-123108.png"
      ],
      "explanation": "<p><strong>Ans. A. i- c, ii- b, iii- a, iv-d</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Incubation Period of Food Poisonings</li><li>\u2022 Some Important Pointers on Food Poisoning -</li><li>\u2022 MC food poisoning - Staphylococcus Food poisoning in less than 6 hours - Staphylococcal FP Prominent symptoms in Botulism FP: Dysphagia, Diplopia, Dysarthria (GIT sympotoms are slight) Food poisoning is an example of: Common source, single exposure epidemic.</li><li>\u2022 MC food poisoning - Staphylococcus</li><li>\u2022 MC food poisoning</li><li>\u2022 Staphylococcus</li><li>\u2022 Food poisoning in less than 6 hours - Staphylococcal FP</li><li>\u2022 less than 6 hours</li><li>\u2022 Staphylococcal FP</li><li>\u2022 Prominent symptoms in Botulism FP: Dysphagia, Diplopia, Dysarthria (GIT sympotoms are slight)</li><li>\u2022 Botulism FP:</li><li>\u2022 Dysphagia, Diplopia, Dysarthria</li><li>\u2022 Food poisoning is an example of: Common source, single exposure epidemic.</li><li>\u2022 Food poisoning</li><li>\u2022 Common source, single exposure epidemic.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Incubation period of food poisoning : Salmonella 12\u201324 hours , Staphylococcal 1\u20136 hours, Botulism 12\u201336 hours, Cl. perfirengens 6\u201324 hours, B. cereus (emetic form) 1\u20136 hours , B. cereus (diarrhoel form) 12\u201324 hours</li><li>\u27a4 Incubation period</li><li>\u27a4 food poisoning</li><li>\u27a4 Salmonella 12\u201324 hours</li><li>\u27a4 Staphylococcal 1\u20136 hours, Botulism 12\u201336 hours, Cl. perfirengens 6\u201324 hours, B. cereus</li><li>\u27a4 1\u20136 hours</li><li>\u27a4 B. cereus</li><li>\u27a4 12\u201324 hours</li><li>\u27a4 Ref: Park 26 th edition (page 277)</li><li>\u27a4 Ref: Park 26 th edition (page 277)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "370eba51",
      "audio": ""
    },
    {
      "text": "A medical resident is participating in an epidemiology training focused on the investigation of food poisoning outbreaks. Understanding the investigative process is crucial for identifying the source of the outbreak, implementing control measures, and preventing future occurrences. The training covers various aspects of outbreak investigation, including the identification of the pathogen, interviewing affected individuals, and inspecting food handling facilities. The resident is asked to identify a true statement regarding the investigation of a food poisoning outbreak. Which of the following statements is true regarding the investigation of a food poisoning outbreak?",
      "options": [
        {
          "label": "A",
          "text": "Both affected and not affected persons are interviewed",
          "correct": true
        },
        {
          "label": "B",
          "text": "Hospitalized persons are interviewed",
          "correct": false
        },
        {
          "label": "C",
          "text": "Only affected persons are interviewed",
          "correct": false
        },
        {
          "label": "D",
          "text": "Only not affected persons are interviewed",
          "correct": false
        }
      ],
      "correct_answer": "A. Both affected and not affected persons are interviewed",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Both affected and not affected persons are interviewed</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Getting food history about suspected meal in a food poisoning outbreak:</li><li>\u2022 food history</li><li>\u2022 suspected meal in a food poisoning</li><li>\u2022 List of each and every dish which was served during that meal is made. Each and every person who attended the meal is interviewed. History of consumption of each and every food item that was served during that meal is noted. Information is recorded.</li><li>\u2022 List of each and every dish which was served during that meal is made.</li><li>\u2022 List of each and every dish</li><li>\u2022 served</li><li>\u2022 meal</li><li>\u2022 made.</li><li>\u2022 Each and every person who attended the meal is interviewed.</li><li>\u2022 Each</li><li>\u2022 every person</li><li>\u2022 attended the meal</li><li>\u2022 interviewed.</li><li>\u2022 History of consumption of each and every food item that was served during that meal is noted.</li><li>\u2022 History of consumption</li><li>\u2022 food item</li><li>\u2022 served</li><li>\u2022 meal is noted.</li><li>\u2022 Information is recorded.</li><li>\u2022 Information</li><li>\u2022 recorded.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 During the Investigation of food poisoning outbreak - Both affected and not affected persons must be interviewed</li><li>\u27a4 During the Investigation</li><li>\u27a4 food poisoning outbreak</li><li>\u27a4 Both affected and not affected</li><li>\u27a4 must</li><li>\u27a4 interviewed</li><li>\u27a4 Ref : Textbook of Community Medicine- Rajvir Bhalwar- 4 th edition (page 672)</li><li>\u27a4 Ref : Textbook of Community Medicine- Rajvir Bhalwar- 4 th edition (page 672)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "89ebbd14",
      "audio": ""
    },
    {
      "text": "A medical intern is conducting a session for healthcare workers on the management of dehydration in diarrheal diseases, emphasizing the use of Oral Rehydration Solutions (ORS). The session includes a discussion on the composition of reduced osmolarity ORS, which is designed to be more effective and have fewer side effects than standard ORS formulations. The intern is aware of some common misconceptions about the composition of reduced osmolarity ORS and aims to address these during the session. Which of the following statements about the composition of reduced osmolarity ORS is NOT correct?",
      "options": [
        {
          "label": "A",
          "text": "Chloride \u2013 65 mmol/ litre",
          "correct": false
        },
        {
          "label": "B",
          "text": "Citrate \u2013 10 mmol/ litre",
          "correct": false
        },
        {
          "label": "C",
          "text": "Potassium \u2013 10 mmol/ litre",
          "correct": true
        },
        {
          "label": "D",
          "text": "Sodium \u2013 75 mmol/ litre",
          "correct": false
        }
      ],
      "correct_answer": "C. Potassium \u2013 10 mmol/ litre",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/12/picture32_SCVUL8k.jpg"
      ],
      "explanation": "<p><strong>Ans. C. Potassium \u2013 10 mmol/litre</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Chloride \u2013 65 mmol/ litre. Correct</li><li>\u2022 Option A. Chloride \u2013 65 mmol/ litre. Correct</li><li>\u2022 Option B. Citrate \u2013 10 mmol/ litre. Correct</li><li>\u2022 Option B. Citrate \u2013 10 mmol/ litre. Correct</li><li>\u2022 Option D. Sodium \u2013 75 mmol/ litre. Correct</li><li>\u2022 Option D. Sodium \u2013 75 mmol/ litre. Correct</li><li>\u2022 Reduced osmolarity ORS: Total osmolarity - 245 mmol/ litre</li><li>\u2022 Comparison of different types of ORS solutions -</li><li>\u2022 -</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 WHO Reduced Osmolarity ORS contains (in mmol/L) - Sodium 75, Potassium 20 , Chloride 65 , Citrate 10 , Glucose 75; Total Osmolar concentration is 245 mmol/L. Ratio of Sodium : Glucose in WHO Reduced Osmolarity ORS - 1 : 1</li><li>\u27a4 WHO Reduced Osmolarity ORS contains (in mmol/L) - Sodium 75, Potassium 20 , Chloride 65 , Citrate 10 , Glucose 75; Total Osmolar concentration is 245 mmol/L.</li><li>\u27a4 WHO</li><li>\u27a4 Reduced Osmolarity ORS</li><li>\u27a4 Sodium 75,</li><li>\u27a4 Potassium 20</li><li>\u27a4 Chloride 65</li><li>\u27a4 Citrate 10</li><li>\u27a4 Glucose 75;</li><li>\u27a4 Total Osmolar</li><li>\u27a4 concentration</li><li>\u27a4 245 mmol/L.</li><li>\u27a4 Ratio of Sodium : Glucose in WHO Reduced Osmolarity ORS - 1 : 1</li><li>\u27a4 Ratio of Sodium</li><li>\u27a4 Glucose</li><li>\u27a4 WHO</li><li>\u27a4 1 : 1</li><li>\u27a4 Ref : Park 26 th edition (page 261)</li><li>\u27a4 Ref : Park 26 th edition (page 261)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4da21c4f",
      "audio": ""
    },
    {
      "text": "A two-year-old child is brought to the emergency department by his parents with symptoms of diarrhea and vomiting for the past 24 hours. The child appears lethargic, and the parents report that he has not had a wet diaper in over 6 hours. The medical team is assessing the child for dehydration, a common complication of gastrointestinal illness in young children. One of the residents is tasked with evaluating the severity of the child's dehydration to determine the appropriate treatment plan. In assessing the severity of dehydration in this two-year-old child, which of the following is NOT a clinical findings would most likely indicate SEVERE dehydration?",
      "options": [
        {
          "label": "A",
          "text": "Rapid and feeble pulse",
          "correct": false
        },
        {
          "label": "B",
          "text": "Skin pinch retracts on 4 seconds",
          "correct": false
        },
        {
          "label": "C",
          "text": "Thirsty and restless",
          "correct": true
        },
        {
          "label": "D",
          "text": "Very dry tongue",
          "correct": false
        }
      ],
      "correct_answer": "C. Thirsty and restless",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/12/picture33.jpg"
      ],
      "explanation": "<p><strong>Ans. C. Thirsty and restless</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Thirsty and restless is symptom of Some Dehydration , NOT Severe</li><li>\u2022 Thirsty and restless</li><li>\u2022 Some Dehydration</li><li>\u2022 NOT</li><li>\u2022 Other 3 options are sign/ symptoms of Severe Dehydration.</li><li>\u2022 Other 3 options</li><li>\u2022 sign/ symptoms</li><li>\u2022 Severe Dehydration.</li><li>\u2022 Sign/ symptom of Severe dehydration :</li><li>\u2022 Sign/ symptom</li><li>\u2022 Severe dehydration</li><li>\u2022 Patient appearance- Drowsy, limp, cold, sweaty, maybe comatose. Radial pulse- Rapid, feeble , sometimes impalpable Blood pressure- Less than 80 mmHg , may be unrecordable Skin elasticity - Pinch retracts very slowly (more than 2 seconds) Tongue- Very dry Anterior fontanelle - Very sunken</li><li>\u2022 Patient appearance- Drowsy, limp, cold, sweaty, maybe comatose.</li><li>\u2022 Drowsy, limp, cold, sweaty,</li><li>\u2022 comatose.</li><li>\u2022 Radial pulse- Rapid, feeble , sometimes impalpable</li><li>\u2022 Rapid, feeble</li><li>\u2022 impalpable</li><li>\u2022 Blood pressure- Less than 80 mmHg , may be unrecordable</li><li>\u2022 Less than 80 mmHg</li><li>\u2022 unrecordable</li><li>\u2022 Skin elasticity - Pinch retracts very slowly (more than 2 seconds)</li><li>\u2022 Skin elasticity</li><li>\u2022 Pinch retracts very slowly</li><li>\u2022 Tongue- Very dry</li><li>\u2022 Tongue- Very dry</li><li>\u2022 Anterior fontanelle - Very sunken</li><li>\u2022 Anterior fontanelle</li><li>\u2022 Very sunken</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 IMNCI guidelines for dehydration and diarrhoea</li></ul>\n<p><strong>References:</strong></p><ul><li>\u21b3 Reference: Park 26 th edition (page 262)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1d29eb03",
      "audio": ""
    },
    {
      "text": "A 3-year-old child presents to the pediatric clinic with a 2-day history of diarrhea. The mother reports that the child has had several episodes of loose stools, some of which contained blood. The child does not have a fever and appears otherwise healthy. The pediatric resident examining the child is considering various infectious causes of bloody diarrhea (dysentery) and recalls that certain pathogens are more commonly associated with this presentation than others. The resident needs to identify which pathogen is least likely to be the cause of this child's bloody diarrhea. Based on the clinical presentation, which of the following pathogens is the least likely cause of bloody diarrhea in this child?",
      "options": [
        {
          "label": "A",
          "text": "Campylobacter jejuni",
          "correct": false
        },
        {
          "label": "B",
          "text": "Entamoeba histolytica",
          "correct": false
        },
        {
          "label": "C",
          "text": "Rotavirus",
          "correct": true
        },
        {
          "label": "D",
          "text": "Shigella",
          "correct": false
        }
      ],
      "correct_answer": "C. Rotavirus",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Rotavirus</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Campylobacter jejuni - Campylobacter infection usually have diarrhea (often bloody) , fever , and stomach cramps . Nausea and vomiting may accompany the diarrhea . Symptoms usually start two to five days after infection and last about one week .</li><li>\u2022 Option A. Campylobacter jejuni</li><li>\u2022 Campylobacter infection</li><li>\u2022 diarrhea</li><li>\u2022 bloody)</li><li>\u2022 fever</li><li>\u2022 stomach cramps</li><li>\u2022 Nausea and vomiting</li><li>\u2022 accompany</li><li>\u2022 diarrhea</li><li>\u2022 start two to five days</li><li>\u2022 infection</li><li>\u2022 last about one week</li><li>\u2022 Option B. Entamoeba histolytica: Invasive intestinal parasitic infection can result in symptoms of fulminant dysentery , such as fever, chills, bloody or mucous diarrhea , and abdominal discomfort .</li><li>\u2022 Option B. Entamoeba histolytica: Invasive intestinal parasitic infection</li><li>\u2022 fulminant dysentery</li><li>\u2022 fever, chills, bloody</li><li>\u2022 mucous diarrhea</li><li>\u2022 abdominal discomfort</li><li>\u2022 Option D. Shigella: Shigellosis usually start experiencing symptoms 1 to 2 days after contact with the germ . These symptoms include: Diarrhea that can be bloody or prolonged (lasting more than 3 days ).</li><li>\u2022 Option D. Shigella: Shigellosis</li><li>\u2022 symptoms 1 to 2 days</li><li>\u2022 contact</li><li>\u2022 the germ</li><li>\u2022 Diarrhea</li><li>\u2022 bloody or prolonged</li><li>\u2022 more than 3 days</li><li>\u2022 Causes of acute gastroenteritis with blood in stool:</li><li>\u2022 Causes of acute gastroenteritis with blood in stool:</li><li>\u2022 Bacteria - Shigellosis, enterohemorrhagic E coli, C. jejuni, Salmonella spp, Yersinia enterocolitica</li><li>\u2022 Bacteria</li><li>\u2022 Protozoa- Entamoeba histolytica, Balantidium coli</li><li>\u2022 Protozoa-</li><li>\u2022 Helminths - Massive trichuris infection, Schistosoma mansoni, S.japonicum</li><li>\u2022 Helminths</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Rota virus , Noro virus is the least likely cause of bloody diarrhea.</li><li>\u27a4 Rota virus</li><li>\u27a4 Noro virus</li><li>\u27a4 least</li><li>\u27a4 bloody diarrhea.</li><li>\u27a4 Causes of acute gastroenteritis with blood in stool - Shigellosis, enterohemorrhagic E coli, C. jejuni , Salmonella spp, Yersinia enterocolitica, Entamoeba histolytica, Balantidium coli, Massive trichuris infection, Schistosoma mansoni, S.japonicum</li><li>\u27a4 acute gastroenteritis</li><li>\u27a4 blood in stool</li><li>\u27a4 Shigellosis,</li><li>\u27a4 enterohemorrhagic E coli, C. jejuni</li><li>\u27a4 Salmonella spp, Yersinia enterocolitica, Entamoeba histolytica, Balantidium coli, Massive trichuris infection, Schistosoma mansoni, S.japonicum</li><li>\u27a4 Ref : Textbook of Community Medicine- Rajvir Bhalwar- 4 th edition (page 661)</li><li>\u27a4 Ref : Textbook of Community Medicine- Rajvir Bhalwar- 4 th edition (page 661)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b042c6d2",
      "audio": ""
    },
    {
      "text": "A pediatric resident is managing a 7-month-old child who presented to the clinic with acute diarrhea. As part of the treatment plan, the resident decides to include zinc supplementation, which is recommended for the management of acute diarrhea in children to reduce the duration and severity of the episode. The resident is aware that the dose of zinc supplementation varies based on the age of the child and is determining the appropriate dose for this 7-month-old patient. What is the recommended dose of zinc supplementation for a 7-month-old child with acute diarrhea, to be given for a duration of 14 days?",
      "options": [
        {
          "label": "A",
          "text": "1 mg",
          "correct": false
        },
        {
          "label": "B",
          "text": "5 mg",
          "correct": false
        },
        {
          "label": "C",
          "text": "10 mg",
          "correct": false
        },
        {
          "label": "D",
          "text": "20 mg",
          "correct": true
        }
      ],
      "correct_answer": "D. 20 mg",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. 20 mg</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 When a zinc supplement is given during an episode of acute diarrhoea , it reduces the episode's duration and severity . In addition, zinc supplements given for 10 to 14 days to lower the incidence of diarrhoea in the following 2 to 3 months.</li><li>\u2022 zinc supplement</li><li>\u2022 acute diarrhoea</li><li>\u2022 reduces</li><li>\u2022 episode's duration and severity</li><li>\u2022 zinc supplements</li><li>\u2022 10 to 14 days</li><li>\u2022 lower</li><li>\u2022 incidence of diarrhoea</li><li>\u2022 2 to 3 months.</li><li>\u2022 WHO and UNICEF therefore recommend daily - 10 mg of zinc for infants under 6 months of age , and 20 mg for children older than 6 months for 10-14 days.</li><li>\u2022 WHO and UNICEF</li><li>\u2022 10 mg of zinc</li><li>\u2022 infants</li><li>\u2022 6 months of age</li><li>\u2022 20 mg</li><li>\u2022 children older</li><li>\u2022 6 months for 10-14 days.</li><li>\u2022 Some important Pointers -</li><li>\u2022 Micronutrient Zinc deficiency associated with rash and diarrhea Acrodermatitis enteropathica is due to Zinc deficiency (Clinical triad of acral dermatitis, alopecia and diarrhea ) Zinc deficiency : Growth failure, Sexual infantilism , Loss of taste , Delayed wound healing , Loss of integrity of immune system , Spontaneous abortions, Congenital malformations, Low birth weight , IUGR, Preterm delivery, Skin lesions , Depressed appetite , Skeletal abnormalities Banana is not a good source of: Calcium, Iron (Due to presence of phytates ) and Zinc.</li><li>\u2022 Micronutrient Zinc deficiency associated with rash and diarrhea</li><li>\u2022 Micronutrient Zinc deficiency associated with rash and diarrhea</li><li>\u2022 Micronutrient Zinc deficiency</li><li>\u2022 rash and diarrhea</li><li>\u2022 Acrodermatitis enteropathica is due to Zinc deficiency (Clinical triad of acral dermatitis, alopecia and diarrhea )</li><li>\u2022 Acrodermatitis enteropathica is due to Zinc deficiency (Clinical triad of acral dermatitis, alopecia and diarrhea )</li><li>\u2022 Acrodermatitis enteropathica</li><li>\u2022 Zinc deficiency</li><li>\u2022 acral dermatitis, alopecia and diarrhea</li><li>\u2022 Zinc deficiency : Growth failure, Sexual infantilism , Loss of taste , Delayed wound healing , Loss of integrity of immune system , Spontaneous abortions, Congenital malformations, Low birth weight , IUGR, Preterm delivery, Skin lesions , Depressed appetite , Skeletal abnormalities</li><li>\u2022 Zinc deficiency : Growth failure, Sexual infantilism , Loss of taste , Delayed wound healing , Loss of integrity of immune system , Spontaneous abortions, Congenital malformations, Low birth weight , IUGR, Preterm delivery, Skin lesions , Depressed appetite , Skeletal abnormalities</li><li>\u2022 Zinc deficiency</li><li>\u2022 Growth failure, Sexual infantilism</li><li>\u2022 Loss of taste</li><li>\u2022 wound healing</li><li>\u2022 immune system</li><li>\u2022 Low birth weight</li><li>\u2022 Skin lesions</li><li>\u2022 Depressed appetite</li><li>\u2022 Banana is not a good source of: Calcium, Iron (Due to presence of phytates ) and Zinc.</li><li>\u2022 Banana is not a good source of: Calcium, Iron (Due to presence of phytates ) and Zinc.</li><li>\u2022 Banana</li><li>\u2022 not</li><li>\u2022 good source</li><li>\u2022 presence</li><li>\u2022 phytates</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Zinc supplementation :</li><li>\u27a4 Zinc supplementation</li><li>\u27a4 Infants < 6 months age: 10 mg/day \u00d7 10\u201314 days. Children > 6 months age: 20 mg/day \u00d7 10\u201314 days.</li><li>\u27a4 Infants < 6 months age: 10 mg/day \u00d7 10\u201314 days.</li><li>\u27a4 Infants < 6 months</li><li>\u27a4 10 mg/day \u00d7 10\u201314 days.</li><li>\u27a4 Children > 6 months age: 20 mg/day \u00d7 10\u201314 days.</li><li>\u27a4 Children > 6 months</li><li>\u27a4 20 mg/day \u00d7 10\u201314 days.</li><li>\u27a4 Ref : Park 26 th edition (page 264)</li><li>\u27a4 Ref : Park 26 th edition (page 264)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "edc68af9",
      "audio": ""
    },
    {
      "text": "A medical resident is consulting on a case in the emergency department involving a group of individuals who presented with symptoms of food poisoning after attending a buffet. The resident is considering the various pathogens that could be responsible based on the type of onset and nature of the toxins involved. While some foodborne illnesses are caused by preformed toxins, others result from toxins produced in the body after consuming contaminated food. The resident needs to determine which pathogen in this scenario is least likely to be associated with preformed toxins in the context of food poisoning. In the case of the group presenting with food poisoning after a buffet, which pathogen is least likely to be associated with illness caused by preformed toxins?",
      "options": [
        {
          "label": "A",
          "text": "Bacillus cereus",
          "correct": false
        },
        {
          "label": "B",
          "text": "Botulism",
          "correct": false
        },
        {
          "label": "C",
          "text": "Clostridium Perfringens",
          "correct": true
        },
        {
          "label": "D",
          "text": "Staphylococcus",
          "correct": false
        }
      ],
      "correct_answer": "C. Clostridium Perfringens",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Clostridium perfringens</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Bacillus cereus: Emetic type causes illness through the ingestion of preformed toxins</li><li>\u2022 Option A. Bacillus cereus: Emetic type</li><li>\u2022 preformed toxins</li><li>\u2022 Option B. Botulism: Is caused by the ingestion of a preformed toxin in contaminated food . The toxin is produced when the bacteria grow in food that has been improperly preserved , or stored under anaerobic conditions .</li><li>\u2022 Option B. Botulism:</li><li>\u2022 preformed toxin</li><li>\u2022 contaminated food</li><li>\u2022 bacteria grow in food</li><li>\u2022 improperly preserved</li><li>\u2022 stored under anaerobic conditions</li><li>\u2022 Option D. Staphylococcus - Mechanism of food poisoning: Intra-dietetic toxins (ingestion of toxins pre-formed in food, in which bacteria have grown ). Incubation period ( 1\u20136 hours ) is short because of \u2018preformed toxin \u2019. Toxins are relatively heat stable and resist boiling for 30 min or more.</li><li>\u2022 Option D. Staphylococcus</li><li>\u2022 Mechanism</li><li>\u2022 Intra-dietetic toxins</li><li>\u2022 bacteria</li><li>\u2022 grown</li><li>\u2022 1\u20136 hours</li><li>\u2022 short</li><li>\u2022 \u2018preformed</li><li>\u2022 toxin</li><li>\u2022 relatively heat stable</li><li>\u2022 resist</li><li>\u2022 30 min</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Clostridium botulinum, Staphylococcus aureus, and Bacillus cereus ( emetic type ) cause illness through the ingestion of preformed toxins present in the food .</li><li>\u27a4 Clostridium botulinum, Staphylococcus aureus, and Bacillus cereus</li><li>\u27a4 emetic type</li><li>\u27a4 illness</li><li>\u27a4 ingestion</li><li>\u27a4 preformed toxins</li><li>\u27a4 food</li><li>\u27a4 Ref: Park 26 th edition (page 276)</li><li>\u27a4 Ref: Park 26 th edition (page 276)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "bb37d50f",
      "audio": ""
    },
    {
      "text": "A public health physician is managing a recent outbreak of cholera in a coastal community. One of the patients, a 40-year-old man, has recently recovered from a severe case of cholera. Despite clinical recovery, follow-up testing reveals that he is still excreting Vibrio cholerae in his stool. This information is critical for the public health team in understanding the dynamics of disease transmission post-recovery. The physician needs to categorize this patient correctly in terms of carrier status to inform further public health actions. In the context of a cholera outbreak, how should the public health physician categorize a patient who continues to excrete Vibrio cholerae in his stool 2 to 3 weeks after clinical recovery?",
      "options": [
        {
          "label": "A",
          "text": "Chronic carrier",
          "correct": false
        },
        {
          "label": "B",
          "text": "Contact carrier",
          "correct": false
        },
        {
          "label": "C",
          "text": "Convalescent carrier",
          "correct": true
        },
        {
          "label": "D",
          "text": "Incubatory carrier",
          "correct": false
        }
      ],
      "correct_answer": "C. Convalescent carrier",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/08/screenshot-2024-08-08-122809.png"
      ],
      "explanation": "<p><strong>Ans. \u00a0C. Convalescent carrier</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Chronic carrier:  Excretes infectious agents for indefinite periods (> 6 months). Example - Typhoid, Hepatitis-B, Dysentery, Meningococcal Meningitis, Malaria, Gonorrhoea, etc.</li><li>\u2022 Option A. Chronic carrier:  Excretes infectious agents</li><li>\u2022 indefinite periods</li><li>\u2022 Option B. Contact carrier: Carrier who gets infected from a case.</li><li>\u2022 Option B. Contact carrier:</li><li>\u2022 infected from a case.</li><li>\u2022 Option D. Incubatory carrier: Shed infectious agent during incubation period of disease. Example - Measles, Mumps, Polio, Pertussis, Influenza, Diphtheria, Hepatitis-B</li><li>\u2022 Option D. Incubatory carrier: Shed infectious agent</li><li>\u2022 incubation period</li><li>\u2022 Measles, Mumps, Polio, Pertussis, Influenza, Diphtheria, Hepatitis-B</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Convalescent Carriers : Shed the disease agent during the period of Convalescence , e.g. Typhoid, Bacillary Dysentery, Amoebic Dysentery, Cholera, Diphtheria & Pertussis (Clinical recovery does not coincide with bacteriological recovery)</li><li>\u27a4 Convalescent Carriers</li><li>\u27a4 disease agent</li><li>\u27a4 period</li><li>\u27a4 Convalescence</li><li>\u27a4 Typhoid, Bacillary Dysentery, Amoebic Dysentery, Cholera, Diphtheria & Pertussis</li><li>\u27a4 Different types of carriers of a disease</li><li>\u27a4 Different types of carriers of a disease</li></ul>\n<p><strong>References:</strong></p><ul><li>\u21b3 Reference: Park 26 th edition (page 267)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f8cdcd7a",
      "audio": ""
    },
    {
      "text": "A public health officer is investigating a potential water contamination event in a small community. To determine whether there is fecal contamination of the water supply, the officer decides to test for the presence of specific bacteria. Which bacterial indicator is primarily used to identify fecal contamination of water?",
      "options": [
        {
          "label": "A",
          "text": "Streptococci",
          "correct": false
        },
        {
          "label": "B",
          "text": "Clostridia",
          "correct": false
        },
        {
          "label": "C",
          "text": "E coli",
          "correct": true
        },
        {
          "label": "D",
          "text": "Klebsiella",
          "correct": false
        }
      ],
      "correct_answer": "C. E coli",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. E coli</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 The primary bacterial indicator is the coliform group of organisms.</li><li>\u2022 primary bacterial indicator</li><li>\u2022 coliform</li><li>\u2022 organisms.</li><li>\u2022 Reasons for choosing coliforms as indicators of fecal pollution rather than water\u2013 Borne pathogens :</li><li>\u2022 Reasons for choosing coliforms as indicators of fecal pollution</li><li>\u2022 Borne pathogens</li><li>\u2022 1. Constant presence in great abundance in human intestine ; foreign to potable waters 2. Easily detectable by culture methods 3. Longer survival period 4. Greater resistance to forces of natural purification.</li><li>\u2022 Constant presence</li><li>\u2022 abundance</li><li>\u2022 human intestine</li><li>\u2022 foreign</li><li>\u2022 potable waters</li><li>\u2022 detectable</li><li>\u2022 culture methods</li><li>\u2022 Longer survival period</li><li>\u2022 Greater resistance</li><li>\u2022 natural purification.</li><li>\u2022 Supplementary indicator organisms- faecal streptococci and sulphite-reducing clostridia, may be useful in determining the origin of faecal pollution as well as in assessing the efficiency of water treatment processes .</li><li>\u2022 Supplementary</li><li>\u2022 faecal streptococci and sulphite-reducing clostridia,</li><li>\u2022 useful</li><li>\u2022 origin of faecal pollution</li><li>\u2022 efficiency</li><li>\u2022 water treatment processes</li><li>\u2022 Bacteriological indicators of water quality:</li><li>\u2022 Bacteriological indicators of water quality:</li><li>\u2022 Coliforms (E.coli is MOST important microbiological indicator ) Fecal streptococci (Indicator of RECENT contamination) (Sodium Azide medium) Clostridium perfringens (Indicator of REMOTE contamination)</li><li>\u2022 Coliforms (E.coli is MOST important microbiological indicator )</li><li>\u2022 Coliforms</li><li>\u2022 MOST</li><li>\u2022 microbiological indicator</li><li>\u2022 Fecal streptococci (Indicator of RECENT contamination) (Sodium Azide medium)</li><li>\u2022 Fecal streptococci</li><li>\u2022 RECENT</li><li>\u2022 Clostridium perfringens (Indicator of REMOTE contamination)</li><li>\u2022 Clostridium perfringens</li><li>\u2022 REMOTE</li><li>\u2022 Acceptable level of coliforms in drinking water: NONE</li><li>\u2022 Acceptable level of coliforms in drinking water: NONE</li><li>\u2022 EXCEPTION: In large urban supplies, up to 5% samples are acceptable to be contaminated if taken continuously for a period of 12 month.</li><li>\u2022 EXCEPTION: In large urban supplies, up to 5% samples are acceptable to be contaminated if taken continuously for a period of 12 month.</li><li>\u2022 EXCEPTION:</li><li>\u2022 large urban</li><li>\u2022 5% samples</li><li>\u2022 contaminated</li><li>\u2022 continuously</li><li>\u2022 12 month.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Coliform organisms are the Primary & most reliable bacterial indicator for water quality.</li><li>\u27a4 Coliform organisms</li><li>\u27a4 Primary</li><li>\u27a4 reliable bacterial indicator</li><li>\u27a4 water quality.</li><li>\u27a4 Fecal streptococci indicates \u2018 recent contamination of water \u2019 and Clostridium perfringens indicates \u2018 remote contamination of water\u2019</li><li>\u27a4 Fecal streptococci</li><li>\u27a4 recent contamination</li><li>\u27a4 water</li><li>\u27a4 Clostridium</li><li>\u27a4 perfringens</li><li>\u27a4 remote contamination</li><li>\u27a4 water\u2019</li></ul>\n<p><strong>References:</strong></p><ul><li>\u21b3 Reference: Park 26 th ed pg 814.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e96b6734",
      "audio": ""
    },
    {
      "text": "A physician is consulting a community on setting up a safe drinking water supply. They are discussing various quality parameters that need to be checked to ensure the water's safety. What is the WHO recommended standard level of chloride in drinking water?",
      "options": [
        {
          "label": "A",
          "text": "100 mg/L",
          "correct": false
        },
        {
          "label": "B",
          "text": "250 mg/L",
          "correct": true
        },
        {
          "label": "C",
          "text": "500 mg/L",
          "correct": false
        },
        {
          "label": "D",
          "text": "750 mg/L",
          "correct": false
        }
      ],
      "correct_answer": "B. 250 mg/L",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. 250 mg/L</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 The standared prescribed for chloride is 250 mg/L</li><li>\u2022 The maximum permissible level is 1000 mg/L (in absence of alternative water source)</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Chloride level of 250 mg/L is said to be accepted by WHO</li></ul>\n<p><strong>References:</strong></p><ul><li>\u21b3 Reference: Park 26 th ed pg 813.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c0a7cb62",
      "audio": ""
    },
    {
      "text": "A homeowner is attempting to resolve the issue of hard water in his household plumbing system. He understands that certain compounds are responsible for permanent hardness in water. Which of the following compounds does not contribute to permanent hardness in water?",
      "options": [
        {
          "label": "A",
          "text": "Calcium Chlorides",
          "correct": false
        },
        {
          "label": "B",
          "text": "Calcium bicarbonate",
          "correct": true
        },
        {
          "label": "C",
          "text": "Calcium sulphate",
          "correct": false
        },
        {
          "label": "D",
          "text": "Calcium Nitrates",
          "correct": false
        }
      ],
      "correct_answer": "B. Calcium bicarbonate",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/17/screenshot-2024-08-17-120518.png",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/17/screenshot-2024-08-17-120525.png"
      ],
      "explanation": "<p><strong>Ans. B. Calcium bicarbonate.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Temporary hardness (carbonate hardness)- due to the presence of calcium and magnesium bicarbonates.</li><li>\u2022 Temporary hardness</li><li>\u2022 calcium</li><li>\u2022 magnesium bicarbonates.</li><li>\u2022 Permanent hardness (Non-carbonate hardness)- due to calcium and magnesium sulphates, chlorides, and nitrates.</li><li>\u2022 Permanent hardness</li><li>\u2022 calcium and</li><li>\u2022 magnesium sulphates, chlorides, and nitrates.</li><li>\u2022 Hardness of Water</li><li>\u2022 Hardness of Water</li><li>\u2022 Hardness of water is defined as the \u2018 soap destroying power of water\u2019 Hardness of water is expressed in terms of: milliequivalents per litre ( mEq/litre ) of CALCIUM CARBONATE (CaCO3) \u2013 1 mEq/litre hardness = 50 mg CaCO3 (50 ppm) per litre of water Classification of hardness in water:</li><li>\u2022 Hardness of water is defined as the \u2018 soap destroying power of water\u2019</li><li>\u2022 soap destroying power</li><li>\u2022 water\u2019</li><li>\u2022 Hardness of water is expressed in terms of: milliequivalents per litre ( mEq/litre ) of CALCIUM CARBONATE (CaCO3) \u2013 1 mEq/litre hardness = 50 mg CaCO3 (50 ppm) per litre of water</li><li>\u2022 Hardness</li><li>\u2022 water</li><li>\u2022 milliequivalents</li><li>\u2022 litre</li><li>\u2022 mEq/litre</li><li>\u2022 CALCIUM CARBONATE</li><li>\u2022 1 mEq/litre hardness</li><li>\u2022 50 mg CaCO3</li><li>\u2022 Classification of hardness in water:</li><li>\u2022 Classification</li><li>\u2022 hardness</li><li>\u2022 water:</li><li>\u2022 Softening of water is recommended at level of hardness > 3 mEq/litre (>150 mg/litre of Calcium carbonate)</li><li>\u2022 Softening</li><li>\u2022 water</li><li>\u2022 at level</li><li>\u2022 > 3 mEq/litre</li><li>\u2022 Methods of removal of hardness of water:</li><li>\u2022 Methods of removal of hardness of water:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Temporary hardness ( carbonate hardness) is due to the presence of calcium and magnesium bicarbonates and Permanent hardness (Non-carbonate hardness) is due to calcium and magnesium sulphates, chlorides and nitrates .</li><li>\u27a4 Temporary hardness</li><li>\u27a4 carbonate</li><li>\u27a4 calcium</li><li>\u27a4 magnesium bicarbonates</li><li>\u27a4 Permanent hardness</li><li>\u27a4 calcium</li><li>\u27a4 magnesium sulphates, chlorides</li><li>\u27a4 nitrates</li><li>\u27a4 Ref : Park 26 th ed pg 820.</li><li>\u27a4 Ref : Park 26 th ed pg 820.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "49bf5573",
      "audio": ""
    },
    {
      "text": "A public health official is reviewing the safety standards for drinking water in a community. He is particularly concerned about the levels of nitrate and nitrite, as these can have harmful effects on health. What are the recommended guideline values for nitrate and nitrite in water to ensure its safety for consumption?",
      "options": [
        {
          "label": "A",
          "text": "25 mg/l and 0.5 mg/l",
          "correct": false
        },
        {
          "label": "B",
          "text": "10 mg/l and 1 mg/l",
          "correct": false
        },
        {
          "label": "C",
          "text": "30 mg/l and 10 mg/l",
          "correct": false
        },
        {
          "label": "D",
          "text": "45 mg/l and 3 mg/l",
          "correct": true
        }
      ],
      "correct_answer": "D. 45 mg/l and 3 mg/l",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/17/screenshot-2024-08-17-121027.png"
      ],
      "explanation": "<p><strong>Ans. D. 45 mg/l and 3 mg/l</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Key Guideline Aspects Recommended Drinking Water Quality</li><li>\u2022 Key Guideline Aspects Recommended Drinking Water Quality</li><li>\u2022 Colour < 15 true colour units (TCU) [< 5 Hazen units] Turbidity < 1 nephlometric turbidity units (NTU) Hardness < 100\u2013300 mg/litre calcium ion pH: 6.5\u20138.5 Total dissolved solids (TDS) < 500 mg/litre *(BIS 2017) Zero pathogenic microorganisms Zero infectious viruses Absence of pathogenic protozoa and infective stages of helminths Fluoride < 1 ppm (0.5\u20130.8 ppm: Optimum level) Nitrates < 45 mg/L Nitrites < 3 mg/L Gross alpha radiological activity < 0.5 Bq/L [New Guideline \u2014 WHO] Gross beta radiological activity < 1.0 Bq/L [New Guideline \u2014 WHO]</li><li>\u2022 Colour < 15 true colour units (TCU) [< 5 Hazen units]</li><li>\u2022 Colour < 15 true colour</li><li>\u2022 Turbidity < 1 nephlometric turbidity units (NTU)</li><li>\u2022 Turbidity < 1 nephlometric turbidity units (NTU)</li><li>\u2022 Hardness < 100\u2013300 mg/litre calcium ion</li><li>\u2022 Hardness < 100\u2013300 mg/litre</li><li>\u2022 pH: 6.5\u20138.5</li><li>\u2022 pH: 6.5\u20138.5</li><li>\u2022 Total dissolved solids (TDS) < 500 mg/litre *(BIS 2017)</li><li>\u2022 Zero pathogenic microorganisms</li><li>\u2022 Zero pathogenic microorganisms</li><li>\u2022 Zero infectious viruses</li><li>\u2022 Zero infectious viruses</li><li>\u2022 Absence of pathogenic protozoa and infective stages of helminths</li><li>\u2022 Absence</li><li>\u2022 protozoa</li><li>\u2022 helminths</li><li>\u2022 Fluoride < 1 ppm (0.5\u20130.8 ppm: Optimum level) Nitrates < 45 mg/L Nitrites < 3 mg/L</li><li>\u2022 Nitrates < 45 mg/L</li><li>\u2022 Nitrites < 3 mg/L</li><li>\u2022 Gross alpha radiological activity < 0.5 Bq/L [New Guideline \u2014 WHO]</li><li>\u2022 Gross beta radiological activity < 1.0 Bq/L [New Guideline \u2014 WHO]</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Key Guideline Aspects of NPCB (India) Recommended Drinking Water Quality</li><li>\u27a4 Key Guideline Aspects of NPCB (India) Recommended Drinking Water Quality</li><li>\u27a4 Ref : Park 26 th ed pg 817.</li><li>\u27a4 Ref : Park 26 th ed pg 817.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6f9f3808",
      "audio": ""
    },
    {
      "text": "A rural community is seeking guidance on safe water practices, particularly in relation to the construction of sanitary wells. As a Medical officer incharge of the serving community, you need to advise them on the importance of maintaining an adequate distance between the well and potential sources of contamination to prevent water contamination and ensure safe drinking water. What is the minimum recommended distance for this purpose?",
      "options": [
        {
          "label": "A",
          "text": "35 meters",
          "correct": false
        },
        {
          "label": "B",
          "text": "15 meters",
          "correct": true
        },
        {
          "label": "C",
          "text": "25 meters",
          "correct": false
        },
        {
          "label": "D",
          "text": "50 meters",
          "correct": false
        }
      ],
      "correct_answer": "B. 15 meters",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. 15 meters</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Sanitary Well Guidelines</li><li>\u2022 Sanitary Well Guidelines</li><li>\u2022 Location: <100 m radial distance; >15 m (50 feet) from source of contamination Lining: >6 m (20 feet) depth ; >60-90 cm (2-3 feet) above ground level Parapet wall : >70-75 cms above ground Platform: >1 m (3 feet) in all directions Other guidelines: Pucca drain to a soakage pit/public drain beyond cone of filtration ; cement concrete cover ; robust hand pump to withdraw water.</li><li>\u2022 Location: <100 m radial distance; >15 m (50 feet) from source of contamination</li><li>\u2022 <100 m</li><li>\u2022 >15 m (50 feet) from source of contamination</li><li>\u2022 Lining: >6 m (20 feet) depth ; >60-90 cm (2-3 feet) above ground level</li><li>\u2022 >6 m (20 feet) depth</li><li>\u2022 >60-90 cm (2-3 feet)</li><li>\u2022 Parapet wall : >70-75 cms above ground</li><li>\u2022 Parapet wall</li><li>\u2022 >70-75 cms</li><li>\u2022 Platform: >1 m (3 feet) in all directions</li><li>\u2022 Platform: >1 m (3 feet)</li><li>\u2022 Other guidelines: Pucca drain to a soakage pit/public drain beyond cone of filtration ; cement concrete cover ; robust hand pump to withdraw water.</li><li>\u2022 Pucca drain</li><li>\u2022 soakage pit/public drain</li><li>\u2022 cone</li><li>\u2022 filtration</li><li>\u2022 cement concrete cover</li><li>\u2022 robust hand pump</li><li>\u2022 water.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 If bacterial contamination is to be avoided , the well should be located not less than 15 m (50 feet) from likely sources of contamination.</li><li>\u27a4 bacterial contamination</li><li>\u27a4 avoided</li><li>\u27a4 located</li><li>\u27a4 not</li><li>\u27a4 15 m (50 feet)</li><li>\u27a4 contamination.</li><li>\u27a4 Ref : Park 26 th ed pg 803.</li><li>\u27a4 Ref : Park 26 th ed pg 803.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "61760ca5",
      "audio": ""
    },
    {
      "text": "A medical student in India is studying substance abuse disorders and is interested in understanding the epidemiology of substance abuse in the region. She is focusing on the most commonly abused substances in India. Based on prevalence and usage statistics, which of the following substances is the most commonly abused agent in India?",
      "options": [
        {
          "label": "A",
          "text": "Cannabis indica",
          "correct": false
        },
        {
          "label": "B",
          "text": "Tobacco",
          "correct": true
        },
        {
          "label": "C",
          "text": "Heroine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Amphetamine",
          "correct": false
        }
      ],
      "correct_answer": "B. Tobacco",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Tobacco</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Cannabis indica: Is the \u2018most widely used drug today\u2019 (Most commonly abused Narcotic substance). The most common reaction is Dreamy state of altered consciousness. Available forms of Cannabis are -</li><li>\u2022 Option A. Cannabis</li><li>\u2022 indica:</li><li>\u2022 \u2018most widely used drug today\u2019</li><li>\u2022 Bhang: Dried leaves and flowering shoots Hashish/Charas: Resinous exudates from flowering tops of the female plant Ganja: Resinous mass from small leaves and brackets of inflorescence Marijuana: Refer to any part of plant that induces somatic and psychic changes in man</li><li>\u2022 Bhang: Dried leaves and flowering shoots</li><li>\u2022 Bhang:</li><li>\u2022 Hashish/Charas: Resinous exudates from flowering tops of the female plant</li><li>\u2022 Hashish/Charas:</li><li>\u2022 Ganja: Resinous mass from small leaves and brackets of inflorescence</li><li>\u2022 Ganja:</li><li>\u2022 Marijuana: Refer to any part of plant that induces somatic and psychic changes in man</li><li>\u2022 Marijuana:</li><li>\u2022 Option C. Heroin: \u2018 Heroin addiction is worst type of addiction\u2019 . Heroin is Di-acetyl-morphine</li><li>\u2022 Option</li><li>\u2022 C. Heroin:</li><li>\u2022 Heroin addiction</li><li>\u2022 worst type of addiction\u2019</li><li>\u2022 Di-acetyl-morphine</li><li>\u2022 Option D.  Amphetamine : Synthetic drug structurally similar to adrenaline , known as \u2018Superman drugs\u2019 : This causes tremendous boost to energy and self-confidence.</li><li>\u2022 Option</li><li>\u2022 D.  Amphetamine</li><li>\u2022 Synthetic drug</li><li>\u2022 adrenaline</li><li>\u2022 \u2018Superman drugs\u2019</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In India , tobacco use is the most prevalent form of substance abuse , posing significant public health challenges . Awareness of the most commonly abused substances is crucial for healthcare professionals for effective public health interventions, policy-making, and patient counseling.</li><li>\u27a4 India</li><li>\u27a4 tobacco use</li><li>\u27a4 most prevalent form</li><li>\u27a4 substance abuse</li><li>\u27a4 posing</li><li>\u27a4 public health challenges</li><li>\u27a4 Ref :  Park 23/e p834-835, 27/e p962</li><li>\u27a4 Ref :  Park 23/e p834-835, 27/e p962</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "156b26c5",
      "audio": ""
    },
    {
      "text": "A 35-year-old man with a history of bipolar disorder visits a community health center for his regular follow-up. The physician explains the available resources under the District Mental Health Program (DMHP) for patients like him. Which of the following services or components is NOT typically a part of the District Mental Health Program?",
      "options": [
        {
          "label": "A",
          "text": "House to house screening",
          "correct": true
        },
        {
          "label": "B",
          "text": "Training",
          "correct": false
        },
        {
          "label": "C",
          "text": "Public awareness",
          "correct": false
        },
        {
          "label": "D",
          "text": "Record keeping",
          "correct": false
        }
      ],
      "correct_answer": "A. House to house screening",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. House to house screening</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Other 3 options are major components under DMHP</li><li>\u2022 3 options</li><li>\u2022 major components</li><li>\u2022 DMHP</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 DMHP was based on \u2018Bellary Model\u2019 with the following components -</li><li>\u27a4 DMHP</li><li>\u27a4 \u2018Bellary Model\u2019</li><li>\u27a4 -</li><li>\u27a4 Early detection and treatment Training: Imparting short-term training to general physicians for diagnosis and treatment of common mental illnesses with limited number of drugs under guidance of specialist; Health workers are being trained in identifying mentally ill persons IEC: Public awareness generation Monitoring: The purpose is for simple Record Keeping.</li><li>\u27a4 Early detection and treatment</li><li>\u27a4 Early detection</li><li>\u27a4 treatment</li><li>\u27a4 Training: Imparting short-term training to general physicians for diagnosis and treatment of common mental illnesses with limited number of drugs under guidance of specialist; Health workers are being trained in identifying mentally ill persons</li><li>\u27a4 Training:</li><li>\u27a4 IEC: Public awareness generation</li><li>\u27a4 IEC:</li><li>\u27a4 Monitoring: The purpose is for simple Record Keeping.</li><li>\u27a4 Monitoring:</li><li>\u27a4 Ref :  Park 26 th edition- page 532</li><li>\u27a4 Ref :  Park 26 th edition- page 532</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "78c63e21",
      "audio": ""
    },
    {
      "text": "A district health officer is discussing the expansion of mental health services in her region with community leaders. She emphasizes the alignment of the district's strategies with those of the National Mental Health Program (NMHP). She provides an overview of the core strategies of the NMHP, hoping to garner community support. Which of the following strategies would NOT be part of her overview about the NMHP?",
      "options": [
        {
          "label": "A",
          "text": "Integration of mental health with primary health care through the NMHP.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Provision of tertiary care institutions for treatment of mental disorders.",
          "correct": false
        },
        {
          "label": "C",
          "text": "Eradicating stigmatization of mentally ill patients.",
          "correct": false
        },
        {
          "label": "D",
          "text": "Free drugs distribution to all mentally ill patients to reduce the economic burden.",
          "correct": true
        }
      ],
      "correct_answer": "D. Free drugs distribution to all mentally ill patients to reduce the economic burden.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Free drugs distribution to all mentally ill patients to reduce the economic burden.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Integration of mental health with primary health care through the NMHP: This is a key strategy of the NMHP , aiming to ensure that mental health services are accessible at the primary health care level and integrated into general health care.</li><li>\u2022 Option</li><li>\u2022 A. Integration of mental health with primary health care</li><li>\u2022 through the NMHP:</li><li>\u2022 key strategy</li><li>\u2022 NMHP</li><li>\u2022 ensure that mental health services</li><li>\u2022 accessible at the primary health care level</li><li>\u2022 Option B. Provision of tertiary care institutions for treatment of mental disorders : Establishing specialized institutions for the treatment of severe or complicated mental disorders is another important aspect of the NMHP . These institutions provide advanced care and support for patients requiring specialized treatment.</li><li>\u2022 Option</li><li>\u2022 B. Provision of tertiary care institutions</li><li>\u2022 for treatment of mental disorders</li><li>\u2022 :</li><li>\u2022 specialized institutions</li><li>\u2022 treatment of severe</li><li>\u2022 important aspect</li><li>\u2022 NMHP</li><li>\u2022 Option C. Eradicating stigmatization of mentally ill patients : The NMHP often includes initiatives to reduce stigma and discrimination against people with mental illnesses . This involves public education campaigns, community engagement, and advocacy to change societal attitudes towards mental health.</li><li>\u2022 Option</li><li>\u2022 C. Eradicating stigmatization</li><li>\u2022 of mentally ill patients</li><li>\u2022 NMHP</li><li>\u2022 initiatives to reduce stigma</li><li>\u2022 discrimination</li><li>\u2022 people with mental illnesses</li><li>\u2022 Understanding the scope and strategies of national mental health programs is crucial for effective planning, implementation, and community engagement in mental health services.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 National Mental Health Program (1982). The functional unit of implementation in NMHP is District. Objectives are -</li><li>\u27a4 National Mental Health Program (1982).</li><li>\u27a4 To ensure the availability and accessibility of minimum mental healthcare for all in the foreseeable future , particularly to the most vulnerable and underprivileged sections of the population . To encourage the application of mental health knowledge in general healthcare and in social development To promote community participation in mental health service development and to stimulate efforts towards self-help in the community</li><li>\u27a4 To ensure the availability and accessibility of minimum mental healthcare for all in the foreseeable future , particularly to the most vulnerable and underprivileged sections of the population .</li><li>\u27a4 availability and accessibility</li><li>\u27a4 minimum mental healthcare</li><li>\u27a4 foreseeable future</li><li>\u27a4 most vulnerable</li><li>\u27a4 underprivileged sections</li><li>\u27a4 population</li><li>\u27a4 To encourage the application of mental health knowledge in general healthcare and in social development</li><li>\u27a4 encourage</li><li>\u27a4 application of mental health knowledge</li><li>\u27a4 general healthcare</li><li>\u27a4 social development</li><li>\u27a4 To promote community participation in mental health service development and to stimulate efforts towards self-help in the community</li><li>\u27a4 promote community</li><li>\u27a4 mental health service development</li><li>\u27a4 stimulate efforts</li><li>\u27a4 self-help</li><li>\u27a4 Ref : Park 26 th edition- page 532</li><li>\u27a4 Ref : Park 26 th edition- page 532</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e0bee679",
      "audio": ""
    },
    {
      "text": "A 23-year-old medical student is organizing a campus awareness campaign about mental health. He wants to align the event with a globally recognized day that focuses on mental health awareness to maximize impact and draw attention. On which date is World Mental Health Day celebrated every year?",
      "options": [
        {
          "label": "A",
          "text": "September 10",
          "correct": false
        },
        {
          "label": "B",
          "text": "October 10",
          "correct": true
        },
        {
          "label": "C",
          "text": "November 10",
          "correct": false
        },
        {
          "label": "D",
          "text": "August 10",
          "correct": false
        }
      ],
      "correct_answer": "B. October 10",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. October 10</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 World Mental Health Day was celebrated for the first time on October 10, 1992 , at the initiative of Deputy Secretary General Richard Hunter .</li><li>\u2022 World Mental Health Day</li><li>\u2022 first time on October 10, 1992</li><li>\u2022 Deputy Secretary General Richard Hunter</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 World Mental Health Day is celebrated every year on October 10th . This day is dedicated to raising awareness of mental health issues around the world and mobilizing efforts in support of mental health.</li><li>\u27a4 World Mental Health Day</li><li>\u27a4 October 10th</li><li>\u27a4 day</li><li>\u27a4 raising awareness</li><li>\u27a4 mental health</li><li>\u27a4 Ref : IAPSM textbook, 1 st ed, pg. 814</li><li>\u27a4 Ref : IAPSM textbook, 1 st ed, pg. 814</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a4d3578e",
      "audio": ""
    },
    {
      "text": "A 45-year-old woman attends a public health seminar. The keynote speaker mentions a health concern that is pervasive and has broad societal impacts but is often under-discussed or overlooked, referring to it as the \"silent epidemic of the century.\" Which of the following conditions is the speaker most likely referencing?",
      "options": [
        {
          "label": "A",
          "text": "Schizophrenia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Depression",
          "correct": false
        },
        {
          "label": "C",
          "text": "Alzheimer\u2019s disease",
          "correct": true
        },
        {
          "label": "D",
          "text": "Paranoia",
          "correct": false
        }
      ],
      "correct_answer": "C. Alzheimer\u2019s disease",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Alzheimer\u2019s disease</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Silent Epidemic is often used interchangeably with \"invisible epidemic\" and \"hidden epidemic .\" It can mean anything from a disease spreading without symptoms for a prolonged period before it is detected to a disease or condition spreading without the individual being known of his/her problem.</li><li>\u2022 Silent Epidemic</li><li>\u2022 interchangeably</li><li>\u2022 \"invisible epidemic\"</li><li>\u2022 \"hidden epidemic</li><li>\u2022 disease spreading</li><li>\u2022 without</li><li>\u2022 prolonged period</li><li>\u2022 detected to a disease</li><li>\u2022 Alzheimer\u2019s disease is often referred to as the \"silent epidemic of the century\" due to its increasing prevalence , particularly in aging populations , and its significant impact on individuals , families , and healthcare systems . Despite its widespread effects, Alzheimer\u2019s disease is frequently under-discussed compared to other health conditions. This is due in part to the gradual onset of symptoms and the fact that it primarily affects older adults, a demographic often less represented in public health discussions.</li><li>\u2022 Alzheimer\u2019s disease</li><li>\u2022 \"silent epidemic of the century\"</li><li>\u2022 increasing prevalence</li><li>\u2022 aging populations</li><li>\u2022 impact on individuals</li><li>\u2022 families</li><li>\u2022 healthcare systems</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Silent Epidemic of the century- Alzheimer\u2019s disease</li><li>\u27a4 Silent Epidemic</li><li>\u27a4 Alzheimer\u2019s disease</li><li>\u27a4 Modern epidemic - Coronary heart disease</li><li>\u27a4 Modern epidemic</li><li>\u27a4 Coronary heart disease</li><li>\u27a4 Most important discovery of 20th century - ORS</li><li>\u27a4 Ref : IAPSM textbook, 1 st ed, pg. 23</li><li>\u27a4 Ref : IAPSM textbook, 1 st ed, pg. 23</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3160b61b",
      "audio": ""
    },
    {
      "text": "A 35-year-old woman presents to her primary care physician with complaints of persistent fatigue, lack of interest in daily activities, and difficulty concentrating. She mentions that these symptoms have affected her ability to work, maintain social relationships, and care for her children. Upon further inquiry, the physician learns that the patient has been experiencing feelings of worthlessness and has had frequent thoughts of death. The physician realizes that this condition is not only affecting this patient but is also a significant global health concern. What condition, which has become the largest single cause of disability worldwide, is this patient most likely suffering from?",
      "options": [
        {
          "label": "A",
          "text": "Cardiovascular diseases",
          "correct": false
        },
        {
          "label": "B",
          "text": "Leprosy",
          "correct": false
        },
        {
          "label": "C",
          "text": "Depression",
          "correct": true
        },
        {
          "label": "D",
          "text": "Diabetes Mellitus",
          "correct": false
        }
      ],
      "correct_answer": "C. Depression",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Depression</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Cardiovascular diseases: While cardiovascular diseases are a leading cause of mortality globally , they do not typically present with symptoms like lack of interest, feelings of worthlessness, or thoughts of death.</li><li>\u2022 Option</li><li>\u2022 A. Cardiovascular diseases:</li><li>\u2022 leading cause</li><li>\u2022 mortality globally</li><li>\u2022 Option B. Leprosy: Leprosy is a chronic infectious disease but is not a leading cause of global disability and does not match the patient's symptom profile.</li><li>\u2022 Option</li><li>\u2022 B. Leprosy:</li><li>\u2022 chronic infectious disease</li><li>\u2022 Option D. Diabetes Mellitus: Diabetes is a major global health issue primarily affecting physical health . It typically does not manifest with the psychological symptoms described in the scenario.</li><li>\u2022 Option</li><li>\u2022 D. Diabetes Mellitus:</li><li>\u2022 major global health issue</li><li>\u2022 affecting physical health</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Depression alone accounts for 4.3% of the global burden of disease and is among the largest single causes of disability worldwide (11% of all years lived with disability globally), particularly for women .</li><li>\u27a4 Depression</li><li>\u27a4 4.3% of the global burden of disease</li><li>\u27a4 largest single</li><li>\u27a4 disability worldwide</li><li>\u27a4 women</li><li>\u27a4 Ref : Park 26 th ed pg. 927</li><li>\u27a4 Ref : Park 26 th ed pg. 927</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ab81fbf7",
      "audio": ""
    },
    {
      "text": "A medical consultant working with a non-governmental organization (NGO) is involved in a project focused on assessing the surveillance capacity for poliomyelitis (polio) in various regions. A critical aspect of this project is the analysis of the reporting rate of acute flaccid paralysis (AFP) cases, which serves as a key surveillance indicator for polio. Accurate detection and reporting of AFP cases are essential for monitoring potential polio outbreaks and guiding eradication efforts. The consultant is tasked with reviewing and understanding the established guidelines for AFP case detection to ensure the efficacy of the surveillance program. What are the established guidelines for detecting AFP cases as part of polio surveillance?",
      "options": [
        {
          "label": "A",
          "text": "1 AFP case for every 100000 children under 15 years of age.",
          "correct": true
        },
        {
          "label": "B",
          "text": "1 AFP case for every 1000 children under 15 years of age.",
          "correct": false
        },
        {
          "label": "C",
          "text": "1 AFP case for every 200000 children under 15 years of age.",
          "correct": false
        },
        {
          "label": "D",
          "text": "1 AFP case for every 10000 children under 15 years of age.",
          "correct": false
        }
      ],
      "correct_answer": "A. 1 AFP case for every 100000 children under 15 years of age.",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/08/screenshot-2024-08-08-113435.png"
      ],
      "explanation": "<p><strong>Ans. A. 1 AFP case for every 100000 children under 15 years of age.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 The number of AFP cases reported each year is used as an indicator of a country's ability to detect polio - even in countries where the disease no longer occurs . A country's surveillance system needs to be sensitive enough to detect at least one case of AFP for every 100,000 children under 15, even in the absence of polio.</li><li>\u2022 AFP cases</li><li>\u2022 each year</li><li>\u2022 indicator</li><li>\u2022 country's ability</li><li>\u2022 detect polio</li><li>\u2022 disease no longer occurs</li><li>\u2022 country's surveillance system</li><li>\u2022 sensitive</li><li>\u2022 detect at least</li><li>\u2022 one</li><li>\u2022 AFP</li><li>\u2022 100,000 children</li><li>\u2022 15,</li><li>\u2022 polio.</li><li>\u2022 Surveillance Indicators -</li><li>\u2022 Surveillance Indicators -</li><li>\u2022 Acute Flaccid Paralysis (AFP) Surveillance</li><li>\u2022 Acute Flaccid Paralysis (AFP) Surveillance</li><li>\u2022 Nationwide AFP (acute flaccid paralysis) surveillance is the gold standard for detecting cases of poliomyelitis . The four steps of surveillance are:</li><li>\u2022 Nationwide AFP</li><li>\u2022 gold standard</li><li>\u2022 poliomyelitis</li><li>\u2022 four steps</li><li>\u2022 Finding and reporting children with acute flaccid paralysis (AFP) Transporting stool samples for analysis Isolating and identifying poliovirus in the laboratory Mapping the virus to determine the origin of the virus strain.</li><li>\u2022 Finding and reporting children with acute flaccid paralysis (AFP)</li><li>\u2022 Finding and reporting children</li><li>\u2022 acute flaccid paralysis (AFP)</li><li>\u2022 Transporting stool samples for analysis</li><li>\u2022 stool samples</li><li>\u2022 analysis</li><li>\u2022 Isolating and identifying poliovirus in the laboratory</li><li>\u2022 Isolating and identifying</li><li>\u2022 poliovirus</li><li>\u2022 laboratory</li><li>\u2022 Mapping the virus to determine the origin of the virus strain.</li><li>\u2022 Mapping</li><li>\u2022 virus strain.</li><li>\u2022 (All reported cases of AFP should be investigated by DIO \u2018within 48 hours\u2019 after notification )</li><li>\u2022 AFP</li><li>\u2022 DIO</li><li>\u2022 48 hours\u2019</li><li>\u2022 notification</li><li>\u2022 Available diagnostic tests for Poliomyelitis \u2013</li><li>\u2022 diagnostic</li><li>\u2022 tests</li><li>\u2022 Poliomyelitis</li><li>\u2022 Stool examination (recommended in every case of AFP) CSF examination Throat examination Blood examination</li><li>\u2022 Stool examination (recommended in every case of AFP)</li><li>\u2022 CSF examination</li><li>\u2022 Throat examination</li><li>\u2022 Blood examination</li><li>\u2022 Acute Flaccid Paralysis (AFP): Acute onset ( < 4 weeks ) in a child aged <15 years , or any case of paralytic illness in a person of any age when polio is suspected.</li><li>\u2022 Acute Flaccid Paralysis</li><li>\u2022 Acute onset</li><li>\u2022 < 4 weeks</li><li>\u2022 <15 years</li><li>\u2022 paralytic illness</li><li>\u2022 polio is suspected.</li><li>\u2022 Acute : rapid progression of from onset to maximum paralysis. Flaccid : loss of muscle tone , \u2018 floppy\u2019 as opposed to spastic or rigid. Paralysis : weakness , loss of voluntary movement. Differential diagnosis of AFP: Descending asymmetric flaccid LMN paralysis Guillain Barre Syndrome (Cytologico-albuminic dissociation). Transverse myelitis (Normal CSF, sensory loss +, bladder dysfunction +). Traumatic neuritis (any age, only one leg involved). Other Non-polio enteric viruses : Coxsackie-B , ECHO, Enterovirus type 70 and 71, Mumps.</li><li>\u2022 Acute : rapid progression of from onset to maximum paralysis.</li><li>\u2022 Acute</li><li>\u2022 rapid progression</li><li>\u2022 onset to maximum paralysis.</li><li>\u2022 Flaccid : loss of muscle tone , \u2018 floppy\u2019 as opposed to spastic or rigid.</li><li>\u2022 Flaccid</li><li>\u2022 loss of muscle tone</li><li>\u2022 floppy\u2019</li><li>\u2022 spastic or rigid.</li><li>\u2022 Paralysis : weakness , loss of voluntary movement.</li><li>\u2022 Paralysis</li><li>\u2022 weakness</li><li>\u2022 loss of voluntary movement.</li><li>\u2022 Differential diagnosis of AFP: Descending asymmetric flaccid LMN paralysis Guillain Barre Syndrome (Cytologico-albuminic dissociation). Transverse myelitis (Normal CSF, sensory loss +, bladder dysfunction +). Traumatic neuritis (any age, only one leg involved). Other Non-polio enteric viruses : Coxsackie-B , ECHO, Enterovirus type 70 and 71, Mumps.</li><li>\u2022 Differential diagnosis</li><li>\u2022 Descending</li><li>\u2022 asymmetric flaccid LMN paralysis</li><li>\u2022 Guillain Barre Syndrome (Cytologico-albuminic dissociation). Transverse myelitis (Normal CSF, sensory loss +, bladder dysfunction +). Traumatic neuritis (any age, only one leg involved). Other Non-polio enteric viruses : Coxsackie-B , ECHO, Enterovirus type 70 and 71, Mumps.</li><li>\u2022 Guillain Barre Syndrome (Cytologico-albuminic dissociation).</li><li>\u2022 Guillain Barre Syndrome</li><li>\u2022 Transverse myelitis (Normal CSF, sensory loss +, bladder dysfunction +).</li><li>\u2022 Transverse myelitis</li><li>\u2022 Traumatic neuritis (any age, only one leg involved).</li><li>\u2022 Traumatic neuritis</li><li>\u2022 Other Non-polio enteric viruses : Coxsackie-B , ECHO, Enterovirus type 70 and 71, Mumps.</li><li>\u2022 Non-polio enteric viruses</li><li>\u2022 Coxsackie-B</li><li>\u2022 ECHO, Enterovirus type 70 and 71, Mumps.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 A country's surveillance system needs to be sensitive enough to detect at least one case of AFP for every 100,000 children under 15 , even in the absence of polio .</li><li>\u27a4 country's surveillance</li><li>\u27a4 sensitive</li><li>\u27a4 detect</li><li>\u27a4 least</li><li>\u27a4 one case of AFP</li><li>\u27a4 100,000 children</li><li>\u27a4 15</li><li>\u27a4 absence</li><li>\u27a4 polio</li><li>\u27a4 Ref : Park 26 th edition (page 237)</li><li>\u27a4 Ref : Park 26 th edition (page 237)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "21f8de4b",
      "audio": ""
    },
    {
      "text": "In a postgraduate teaching seminar focused on infectious diseases, a junior resident is presenting on the various strategies employed in the global initiative to eradicate polio. A significant portion of the presentation is dedicated to discussing 'the switch' \u2013 a pivotal moment in the history of polio eradication efforts. This strategy has played an essential role in the worldwide campaign to halt the transmission of all poliovirus types. The resident aims to explain the specifics of 'the switch' to the attendees, emphasizing its impact on the global fight against polio. In the global efforts to eradicate polio, what specifically does 'the switch' refer to?",
      "options": [
        {
          "label": "A",
          "text": "Replacement of tOPV with bOPV.",
          "correct": true
        },
        {
          "label": "B",
          "text": "Replacement of OPV with IPV.",
          "correct": false
        },
        {
          "label": "C",
          "text": "Both",
          "correct": false
        },
        {
          "label": "D",
          "text": "None of the above",
          "correct": false
        }
      ],
      "correct_answer": "A. Replacement of tOPV with bOPV.",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/12/picture23.jpg"
      ],
      "explanation": "<p><strong>Ans. A. Replacement of tOPV with bOPV.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 The first stage of OPV withdrawal involved a global synchronized cessation of tOPV use between 18th April and 1st May 2016 , replacing tOPV with bOPV containing only type 1 and 3 polioviruses and withdrawing OPV type 2 from all immunization activities called \u201c the Switch \u201d. Once switch is made, tOPV will no longer be used anywhere in the world and manufacturers will no longer supply tOPV.</li><li>\u2022 first stage of OPV</li><li>\u2022 withdrawal</li><li>\u2022 global synchronized cessation</li><li>\u2022 tOPV</li><li>\u2022 18th April and 1st May 2016</li><li>\u2022 replacing tOPV with bOPV</li><li>\u2022 type 1 and 3 polioviruses</li><li>\u2022 withdrawing OPV type 2</li><li>\u2022 all immunization</li><li>\u2022 the Switch</li><li>\u2022 Once switch</li><li>\u2022 tOPV</li><li>\u2022 no</li><li>\u2022 used</li><li>\u2022 world</li><li>\u2022 manufacturers</li><li>\u2022 no</li><li>\u2022 longer</li><li>\u2022 tOPV.</li><li>\u2022 \u201cSWITCH\u201d - Replacing Trivalent OPV with Bivalent OPV.</li><li>\u2022 \u201cSWITCH\u201d</li><li>\u2022 Replacing Trivalent OPV</li><li>\u2022 Bivalent OPV.</li><li>\u2022 Concept: An important transition in the vaccines used to eradicate polio requires removal of all OPVs in the long\u2011term to eliminate rare risks of VAPP and cVDPV Strategy: Withdrawal of OPVs must occur in a globally synchronized manner, starting in April 2016 with a switch from trivalent OPV (tOPV) to bivalent OPV (bOPV), removing the type 2 component (OPV2) from immunization programs of countries. Preparation for the removal of OPVs also includes the introduction of at least one dose of IPV in routine immunization programs in all countries by end of 2015. Indian \u201cSwitch\u201d: National Switch Date : April 25, 2016 National Validation Day : May 09, 2016 (India to be declared free of tOPV) Destroy all tOPV on/after 25th April 2016 IPV in 6 states (UP, Bihar, Madhya Pradesh, Gujarat, Punjab, Assam): One Intramuscular dose given along with 3rd dose of DTP at 14 weeks IPV in other states (Orissa, Andhra Pradesh, Telangana, Tamil Nadu, Kerala, Karnataka, Maharashtra, Puducherry): Fractional dose ( 0.1 mL instead of 0.5 mL) by intradermal route at 6 and 14 weeks from April, 2016 (Right deltoid upper arm)</li><li>\u2022 Concept: An important transition in the vaccines used to eradicate polio requires removal of all OPVs in the long\u2011term to eliminate rare risks of VAPP and cVDPV</li><li>\u2022 vaccines</li><li>\u2022 eradicate polio</li><li>\u2022 all OPVs</li><li>\u2022 long\u2011term</li><li>\u2022 eliminate rare risks</li><li>\u2022 VAPP</li><li>\u2022 cVDPV</li><li>\u2022 Strategy: Withdrawal of OPVs must occur in a globally synchronized manner, starting in April 2016 with a switch from trivalent OPV (tOPV) to bivalent OPV (bOPV), removing the type 2 component (OPV2) from immunization programs of countries. Preparation for the removal of OPVs also includes the introduction of at least one dose of IPV in routine immunization programs in all countries by end of 2015.</li><li>\u2022 Withdrawal of OPVs must occur in a globally synchronized manner, starting in April 2016 with a switch from trivalent OPV (tOPV) to bivalent OPV (bOPV), removing the type 2 component (OPV2) from immunization programs of countries. Preparation for the removal of OPVs also includes the introduction of at least one dose of IPV in routine immunization programs in all countries by end of 2015.</li><li>\u2022 Withdrawal of OPVs must occur in a globally synchronized manner, starting in April 2016 with a switch from trivalent OPV (tOPV) to bivalent OPV (bOPV), removing the type 2 component (OPV2) from immunization programs of countries.</li><li>\u2022 Withdrawal</li><li>\u2022 OPVs</li><li>\u2022 globally synchronized</li><li>\u2022 starting</li><li>\u2022 April 2016</li><li>\u2022 switch from trivalent OPV</li><li>\u2022 bivalent OPV</li><li>\u2022 removing</li><li>\u2022 type 2</li><li>\u2022 from immunization</li><li>\u2022 Preparation for the removal of OPVs also includes the introduction of at least one dose of IPV in routine immunization programs in all countries by end of 2015.</li><li>\u2022 removal of OPVs</li><li>\u2022 introduction</li><li>\u2022 one dose of IPV</li><li>\u2022 routine immunization programs</li><li>\u2022 all countries</li><li>\u2022 2015.</li><li>\u2022 Indian \u201cSwitch\u201d: National Switch Date : April 25, 2016 National Validation Day : May 09, 2016 (India to be declared free of tOPV) Destroy all tOPV on/after 25th April 2016 IPV in 6 states (UP, Bihar, Madhya Pradesh, Gujarat, Punjab, Assam): One Intramuscular dose given along with 3rd dose of DTP at 14 weeks IPV in other states (Orissa, Andhra Pradesh, Telangana, Tamil Nadu, Kerala, Karnataka, Maharashtra, Puducherry): Fractional dose ( 0.1 mL instead of 0.5 mL) by intradermal route at 6 and 14 weeks from April, 2016 (Right deltoid upper arm)</li><li>\u2022 National Switch Date : April 25, 2016 National Validation Day : May 09, 2016 (India to be declared free of tOPV) Destroy all tOPV on/after 25th April 2016 IPV in 6 states (UP, Bihar, Madhya Pradesh, Gujarat, Punjab, Assam): One Intramuscular dose given along with 3rd dose of DTP at 14 weeks IPV in other states (Orissa, Andhra Pradesh, Telangana, Tamil Nadu, Kerala, Karnataka, Maharashtra, Puducherry): Fractional dose ( 0.1 mL instead of 0.5 mL) by intradermal route at 6 and 14 weeks from April, 2016 (Right deltoid upper arm)</li><li>\u2022 National Switch Date : April 25, 2016</li><li>\u2022 National Switch Date</li><li>\u2022 April 25, 2016</li><li>\u2022 National Validation Day : May 09, 2016 (India to be declared free of tOPV)</li><li>\u2022 National Validation Day</li><li>\u2022 May 09, 2016</li><li>\u2022 Destroy all tOPV on/after 25th April 2016</li><li>\u2022 Destroy</li><li>\u2022 tOPV</li><li>\u2022 25th April 2016</li><li>\u2022 IPV in 6 states (UP, Bihar, Madhya Pradesh, Gujarat, Punjab, Assam): One Intramuscular dose given along with 3rd dose of DTP at 14 weeks</li><li>\u2022 IPV</li><li>\u2022 One Intramuscular</li><li>\u2022 with 3rd dose</li><li>\u2022 DTP at 14 weeks</li><li>\u2022 IPV in other states (Orissa, Andhra Pradesh, Telangana, Tamil Nadu, Kerala, Karnataka, Maharashtra, Puducherry): Fractional dose ( 0.1 mL instead of 0.5 mL) by intradermal route at 6 and 14 weeks from April, 2016 (Right deltoid upper arm)</li><li>\u2022 IPV</li><li>\u2022 Fractional dose</li><li>\u2022 0.1 mL</li><li>\u2022 by intradermal</li><li>\u2022 at 6 and 14 weeks</li><li>\u2022 April, 2016</li><li>\u2022 (Right deltoid upper arm)</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 A critical step in eradication of Polio , is \u2018the switch\u2019 which refers to - Replacement of tOPV with bOPV.</li><li>\u27a4 eradication of Polio</li><li>\u27a4 \u2018the switch\u2019</li><li>\u27a4 Replacement of tOPV</li><li>\u27a4 bOPV.</li><li>\u27a4 Ref : Park 26 th edition (page 236)</li><li>\u27a4 Ref : Park 26 th edition (page 236)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "42f61087",
      "audio": ""
    },
    {
      "text": "In an immunization clinic, a junior resident in community medicine is preparing for a training session with interns. The focus is on educating them about the National Immunisation Schedule, specifically the correct administration routes and techniques for various vaccines. An important part of this session is the fractional Inactivated Polio Vaccine (fIPV), a key vaccine in polio eradication efforts. The resident needs to ensure that the interns understand the specific route of administration for fIPV as per the National Immunisation Schedule, as this knowledge is crucial for effective vaccine delivery and patient care. According to the NIS, what is the recommended route of administration for fractional Inactivated Polio Vaccine (fIPV)?",
      "options": [
        {
          "label": "A",
          "text": "Intramuscular",
          "correct": false
        },
        {
          "label": "B",
          "text": "\u200b Intradermal",
          "correct": true
        },
        {
          "label": "C",
          "text": "Subcutaneous",
          "correct": false
        },
        {
          "label": "D",
          "text": "Oral",
          "correct": false
        }
      ],
      "correct_answer": "B. \u200b Intradermal",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/08/screenshot-2024-08-08-124535.png",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/08/screenshot-2024-08-08-125017.png"
      ],
      "explanation": "<p><strong>Ans. B. Intradermal</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 IPV Vs Fractionated IPV (fIPV)</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Fractionated inactivated Polio Vaccine (fIPV) is administered intradermally according to the National Immunisation Schedule.</li><li>\u27a4 Fractionated inactivated Polio Vaccine</li><li>\u27a4 intradermally</li><li>\u27a4 National Immunisation Schedule.</li><li>\u27a4 NEW National Immunization Schedule (NIS) 2023-24</li><li>\u27a4 Note - Age Limits for Delayed Immunization in NIS, India for fIPV is 1 year.</li><li>\u27a4 Age Limits</li><li>\u27a4 Delayed Immunization</li><li>\u27a4 NIS, India</li><li>\u27a4 fIPV is 1 year.</li><li>\u27a4 fIPV is fractionated intradermal at 6 weeks, 14 weeks & 9 months ( 3 doses ).</li><li>\u27a4 fIPV</li><li>\u27a4 fractionated intradermal</li><li>\u27a4 6 weeks, 14 weeks & 9 months</li><li>\u27a4 3 doses</li><li>\u27a4 Ref : Park 26 th edition (page 237)</li><li>\u27a4 Ref : Park 26 th edition (page 237)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ee0453b3",
      "audio": ""
    },
    {
      "text": "An epidemiologist working with a global health organization is developing a training module on outbreak response strategies for various infectious diseases. One of the diseases being focused on is cholera, known for its potential to cause rapid and severe outbreaks, especially in areas with poor water and sanitation facilities. The training module aims to outline the key steps and interventions necessary for an effective response to a cholera outbreak. However, it is also important to clarify common misconceptions about what should not be included in these response strategies. The epidemiologist is preparing a question to test the trainees' understanding of these concepts. In the context of an effective response strategy for a cholera outbreak, which of the following steps is NOT typically recommended?",
      "options": [
        {
          "label": "A",
          "text": "Food safety",
          "correct": false
        },
        {
          "label": "B",
          "text": "Immunisation with whole cell killed parenteral vaccine",
          "correct": true
        },
        {
          "label": "C",
          "text": "Proper excreta disposal",
          "correct": false
        },
        {
          "label": "D",
          "text": "Super chlorination of water",
          "correct": false
        }
      ],
      "correct_answer": "B. Immunisation with whole cell killed parenteral vaccine",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/08/screenshot-2024-08-08-114613.png"
      ],
      "explanation": "<p><strong>Ans. \u00a0B. Immunisation with whole cell killed parenteral vaccine</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Mass vaccination is not recommended in an outbreak of cholera.</li><li>\u2022 Mass vaccination</li><li>\u2022 not</li><li>\u2022 outbreak of cholera.</li><li>\u2022 Guidelines for Cholera Control (WHO):</li><li>\u2022 Cholera Control (WHO):</li><li>\u2022 Verification of diagnosis: Identifying Vibrio cholerae 01 in stools of few patients is sufficient. It is \u2018 not necessary to culture stools of all cases or contacts\u2019. Notification: Cholera is a notifiable disease locally, nationally and internationally. Under International Health Regulations , Cholera is notifiable to WHO by National Govt within 24 hours (no. of cases & deaths to be reported daily and weekly). An area is declared free of Cholera when twice the IP has elapsed since last case. Early case finding: through aggressive case search Establishment of treatment centres Rehydration therapy: through ORS Adjuncts to therapy: Only antibiotics may be used when vomiting stops.</li><li>\u2022 Verification of diagnosis: Identifying Vibrio cholerae 01 in stools of few patients is sufficient. It is \u2018 not necessary to culture stools of all cases or contacts\u2019.</li><li>\u2022 Identifying Vibrio cholerae 01 in stools of few patients is sufficient. It is \u2018 not necessary to culture stools of all cases or contacts\u2019.</li><li>\u2022 Identifying Vibrio cholerae 01 in stools of few patients is sufficient.</li><li>\u2022 Vibrio cholerae 01</li><li>\u2022 stools</li><li>\u2022 few patients</li><li>\u2022 It is \u2018 not necessary to culture stools of all cases or contacts\u2019.</li><li>\u2022 not necessary</li><li>\u2022 culture</li><li>\u2022 all cases or contacts\u2019.</li><li>\u2022 Notification: Cholera is a notifiable disease locally, nationally and internationally. Under International Health Regulations , Cholera is notifiable to WHO by National Govt within 24 hours (no. of cases & deaths to be reported daily and weekly). An area is declared free of Cholera when twice the IP has elapsed since last case.</li><li>\u2022 Notification:</li><li>\u2022 Cholera is a notifiable disease locally, nationally and internationally. Under International Health Regulations , Cholera is notifiable to WHO by National Govt within 24 hours (no. of cases & deaths to be reported daily and weekly). An area is declared free of Cholera when twice the IP has elapsed since last case.</li><li>\u2022 Cholera is a notifiable disease locally, nationally and internationally.</li><li>\u2022 Cholera is a notifiable disease locally, nationally and internationally.</li><li>\u2022 Cholera</li><li>\u2022 disease locally, nationally and internationally.</li><li>\u2022 Under International Health Regulations , Cholera is notifiable to WHO by National Govt within 24 hours (no. of cases & deaths to be reported daily and weekly).</li><li>\u2022 Under International Health Regulations , Cholera is notifiable to WHO by National Govt within 24 hours (no. of cases & deaths to be reported daily and weekly).</li><li>\u2022 International Health Regulations</li><li>\u2022 Cholera</li><li>\u2022 National Govt</li><li>\u2022 24 hours</li><li>\u2022 An area is declared free of Cholera when twice the IP has elapsed since last case.</li><li>\u2022 An area is declared free of Cholera when twice the IP has elapsed since last case.</li><li>\u2022 free of Cholera</li><li>\u2022 twice</li><li>\u2022 IP</li><li>\u2022 elapsed</li><li>\u2022 last case.</li><li>\u2022 Early case finding: through aggressive case search</li><li>\u2022 Establishment of treatment centres</li><li>\u2022 Rehydration therapy: through ORS</li><li>\u2022 ORS</li><li>\u2022 Adjuncts to therapy: Only antibiotics may be used when vomiting stops.</li><li>\u2022 antibiotics</li><li>\u2022 vomiting stops.</li><li>\u2022 Epidemiological investigations : General sanitation measures, epidemiological studies . Sanitation measures: Water control, excreta disposal , food sanitation, disinfection Chemoprophylaxis: Mass chemoprophylaxis is not advised for total community ; is only advisable for household contacts or a closed community. Drug of choice for chemoprophylaxis: Tetracycline To prevent one case of cholera , 10,000 persons need to be given chemoprophylaxis. Health education : most effective prophylactic measure Vaccination - Mass vaccination is not recommended</li><li>\u2022 Epidemiological investigations : General sanitation measures, epidemiological studies .</li><li>\u2022 Epidemiological investigations</li><li>\u2022 General sanitation</li><li>\u2022 epidemiological studies</li><li>\u2022 Sanitation measures: Water control, excreta disposal , food sanitation, disinfection Chemoprophylaxis: Mass chemoprophylaxis is not advised for total community ; is only advisable for household contacts or a closed community. Drug of choice for chemoprophylaxis: Tetracycline</li><li>\u2022 Sanitation</li><li>\u2022 Water control, excreta disposal</li><li>\u2022 Chemoprophylaxis: Mass chemoprophylaxis is not advised for total community ; is only advisable for household contacts or a closed community. Drug of choice for chemoprophylaxis: Tetracycline</li><li>\u2022 Chemoprophylaxis:</li><li>\u2022 Chemoprophylaxis:</li><li>\u2022 Mass chemoprophylaxis is not advised for total community ; is only advisable for household contacts or a closed community.</li><li>\u2022 not advised</li><li>\u2022 total community</li><li>\u2022 household contacts</li><li>\u2022 closed community.</li><li>\u2022 Drug of choice for chemoprophylaxis: Tetracycline</li><li>\u2022 Drug of choice</li><li>\u2022 Tetracycline</li><li>\u2022 To prevent one case of cholera , 10,000 persons need to be given chemoprophylaxis.</li><li>\u2022 prevent one case of cholera</li><li>\u2022 10,000 persons</li><li>\u2022 chemoprophylaxis.</li><li>\u2022 Health education : most effective prophylactic measure</li><li>\u2022 Health education</li><li>\u2022 most effective</li><li>\u2022 Vaccination - Mass vaccination is not recommended</li><li>\u2022 Mass vaccination</li><li>\u2022 not</li><li>\u2022 CHOLERA ORAL VACCINES</li><li>\u2022 Dukoral * (WC-rBS): Monovalent , V cholera O1 plus Recombinant toxin B subunit Sanchol : Bivalent, Serogroups O1 & O139 , No toxin B subunit, No buffer required mORCVAX : Bivalent, Serogroups O1 & O139 , No toxin B subunit, No buffer required CVD103-HgR : Live attenuated, single dose , not produced now</li><li>\u2022 Dukoral * (WC-rBS): Monovalent , V cholera O1 plus Recombinant toxin B subunit</li><li>\u2022 Dukoral</li><li>\u2022 Monovalent</li><li>\u2022 V cholera O1</li><li>\u2022 toxin B</li><li>\u2022 Sanchol : Bivalent, Serogroups O1 & O139 , No toxin B subunit, No buffer required</li><li>\u2022 Sanchol</li><li>\u2022 Bivalent,</li><li>\u2022 Serogroups O1 & O139</li><li>\u2022 mORCVAX : Bivalent, Serogroups O1 & O139 , No toxin B subunit, No buffer required</li><li>\u2022 mORCVAX</li><li>\u2022 Bivalent, Serogroups O1 & O139</li><li>\u2022 CVD103-HgR : Live attenuated, single dose , not produced now</li><li>\u2022 CVD103-HgR</li><li>\u2022 Live attenuated, single dose</li><li>\u2022 not</li><li>\u2022 * Dukoral \u00ae is mainly used for travellers . Two doses of Dukoral\u00ae provide protection against cholera for 2 years.</li><li>\u2022 Dukoral</li><li>\u2022 travellers</li><li>\u2022 Two doses</li><li>\u2022 protection</li><li>\u2022 cholera</li><li>\u2022 for 2 years.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Steps taken during an outbreak of cholera - Verification of diagnosis , Notification , early case finding, treatment & chemoprophylaxis for household contacts, sanitation measures and health education.</li><li>\u27a4 Steps</li><li>\u27a4 outbreak of cholera</li><li>\u27a4 Verification</li><li>\u27a4 diagnosis</li><li>\u27a4 Notification</li><li>\u27a4 early case</li><li>\u27a4 treatment & chemoprophylaxis</li><li>\u27a4 household contacts,</li><li>\u27a4 sanitation</li><li>\u27a4 health education.</li><li>\u27a4 Mass vaccination is not recommended.</li><li>\u27a4 Mass vaccination</li><li>\u27a4 not</li><li>\u27a4 Ref : Textbook of Community Medicine- Rajvir Bhalwar- 4 th edition (page 680)</li><li>\u27a4 Ref : Textbook of Community Medicine- Rajvir Bhalwar- 4 th edition (page 680)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ab98989e",
      "audio": ""
    },
    {
      "text": "A medical researcher is reviewing diagnostic protocols for various bacterial infections. One of the conditions under discussion is typhoid fever, caused by Salmonella typhi. Accurate and timely diagnosis is crucial for the effective management of typhoid fever. The researcher is learning about the various methods used to diagnose this condition and is asked to identify the mainstay of diagnosis for typhoid fever. What is the mainstay of diagnosis for typhoid fever?",
      "options": [
        {
          "label": "A",
          "text": "Blood culture",
          "correct": true
        },
        {
          "label": "B",
          "text": "Gastric aspirate",
          "correct": false
        },
        {
          "label": "C",
          "text": "Stool culture",
          "correct": false
        },
        {
          "label": "D",
          "text": "Widal test",
          "correct": false
        }
      ],
      "correct_answer": "A. Blood culture",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/08/screenshot-2024-08-08-124354.png"
      ],
      "explanation": "<p><strong>Ans. A. Blood culture</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Gastric aspirate: Not used due to low yield</li><li>\u2022 Option B. Gastric aspirate:</li><li>\u2022 Option C. Stool Culture :  Stool cultures can be used for the diagnosis of typhoid fever, particularly in the later stages (3rd week) of the disease.</li><li>\u2022 Option C. Stool Culture</li><li>\u2022 diagnosis</li><li>\u2022 typhoid fever,</li><li>\u2022 later stages (3rd week)</li><li>\u2022 Option D. Widal test: The Widal test, which measures agglutinating antibody levels against Salmonella antigens , It has Moderate sensitivity & specificity .  It is used in settings where blood culture facilities are not available.</li><li>\u2022 Option D. Widal test:</li><li>\u2022 agglutinating antibody levels</li><li>\u2022 Salmonella antigens</li><li>\u2022 Moderate sensitivity & specificity</li><li>\u2022 blood culture</li><li>\u2022 not</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Mainstay of diagnosis of Typhoid fever - Blood Culture</li><li>\u27a4 Laboratory Diagnosis: \u2018BASU\u2019 Mnemonic</li><li>\u27a4 \u2018BASU\u2019</li><li>\u27a4 Ref : Park 26 th edition (page 273)</li><li>\u27a4 Ref : Park 26 th edition (page 273)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "735c2213",
      "audio": ""
    },
    {
      "text": "In a seminar focused on public health and injury prevention, a critical discussion emerges about the leading causes of death resulting from injuries. Understanding the predominant causes of injury-related deaths is essential for formulating effective prevention and response strategies. As of the latest data, which type of injury is recognized as the leading cause of death due to injuries?",
      "options": [
        {
          "label": "A",
          "text": "Suicide",
          "correct": false
        },
        {
          "label": "B",
          "text": "Fall",
          "correct": false
        },
        {
          "label": "C",
          "text": "Road traffic accidents",
          "correct": true
        },
        {
          "label": "D",
          "text": "Drowning",
          "correct": false
        }
      ],
      "correct_answer": "C. Road traffic accidents",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Road traffic accidents</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 The leading cause of injury deaths is road traffic injury , followed by suicide , falls and interpersonal violence .</li><li>\u2022 leading cause of injury deaths</li><li>\u2022 road traffic injury</li><li>\u2022 suicide</li><li>\u2022 falls</li><li>\u2022 interpersonal violence</li><li>\u2022 Accidents and Injuries in India (in Order of Decreasing Numbers) -</li><li>\u2022 Accidents and Injuries in India</li><li>\u2022 Road traffic accidents Work related injuries Burns Violence, Suicide Poisoning Drowning</li><li>\u2022 Road traffic accidents</li><li>\u2022 Work related injuries</li><li>\u2022 Burns</li><li>\u2022 Violence, Suicide</li><li>\u2022 Poisoning</li><li>\u2022 Drowning</li><li>\u2022 Road traffic accidents \u2013</li><li>\u2022 Road traffic accidents</li><li>\u2022 (a) Most common cause of accidental deaths in India (b) More in USA in motor-car users than pedestrians (c) More in number than self-inflicted injuries in India (d) More in number than railway accidents in India (e) Contribute 50% of all injury related deaths in India</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The leading cause of injury deaths is road traffic injury , followed by suicide, falls and interpersonal violence.</li><li>\u27a4 leading cause</li><li>\u27a4 injury deaths</li><li>\u27a4 road traffic injury</li><li>\u27a4 Ref : Park 26 th ed pg 454.</li><li>\u27a4 Ref : Park 26 th ed pg 454.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4624e28c",
      "audio": ""
    },
    {
      "text": "A 13-year-old girl presents to your clinic with joint pain, a recent history of sore throat, and unusual involuntary movements. Based on her presentation, you suspect rheumatic fever and review the major criteria for its diagnosis according to the Jones criteria. Which of the following is NOT considered a major criterion in the diagnosis of rheumatic fever?",
      "options": [
        {
          "label": "A",
          "text": "Chorea",
          "correct": false
        },
        {
          "label": "B",
          "text": "Pan carditis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Polyarthralgia",
          "correct": true
        },
        {
          "label": "D",
          "text": "Subcutaneous nodules",
          "correct": false
        }
      ],
      "correct_answer": "C. Polyarthralgia",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/09/screenshot-2024-08-09-100814.png"
      ],
      "explanation": "<p><strong>Ans. C. Polyarthralgia</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Polyarthalgia is a minor criterion , rest all 3 other options are Major criteria</li><li>\u2022 Polyarthalgia</li><li>\u2022 minor criterion</li><li>\u2022 3 other options</li><li>\u2022 Major criteria</li><li>\u2022 Revised Jones Criteria</li><li>\u2022 Revised Jones Criteria</li><li>\u2022 Major criteria \u2013 carditis, polyarthritis, chorea, erythema marginatum, subcutaneous nodule</li><li>\u2022 Major criteria</li><li>\u2022 Minor Criteria - clinical; fever, polyarthralgia, laboratory; elevated acute phase reactants (erythrocyte sedimentation rate or leukocyte count)</li><li>\u2022 Minor Criteria</li><li>\u2022 Supporting evidence of a preceding streptococcal infection within 45 days - electrocardiogram ; prolonged PR interval , elevated or rising antistreptolysin-0 or other streptococcal antibody , or a positive throat culture , or rapid antigen test for group A streptococcus, or recent scarlet fever.</li><li>\u2022 Supporting evidence</li><li>\u2022 preceding streptococcal infection</li><li>\u2022 45 days</li><li>\u2022 electrocardiogram</li><li>\u2022 prolonged PR interval</li><li>\u2022 elevated</li><li>\u2022 rising antistreptolysin-0</li><li>\u2022 streptococcal antibody</li><li>\u2022 positive throat culture</li><li>\u2022 NEW Revised Jones Criteria</li><li>\u2022 NEW Revised Jones Criteria</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Polyarthralgia is considered a minor criterion in the diagnosis of rheumatic fever according to the Jones criteria , whereas chorea, pancarditis (as part of carditis), and subcutaneous nodules are major criteria.</li><li>\u27a4 Polyarthralgia</li><li>\u27a4 minor criterion</li><li>\u27a4 diagnosis of rheumatic fever</li><li>\u27a4 Jones criteria</li><li>\u27a4 chorea, pancarditis</li><li>\u27a4 subcutaneous nodules</li><li>\u27a4 Ref : Park 26 th ed, pg 427.</li><li>\u27a4 Ref : Park 26 th ed, pg 427.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ab94a2e1",
      "audio": ""
    }
  ]
}